Title - COVID-19 Drug Data in Raw Format Version 7.2.01 (2020.06.01) Provided by IDRB Lab of Innovative Drug Reasearch and Bioinformatics College of Pharmaceutical Sciences Zhejiang University https://idrblab.org/ Any question about data provided here, please contact with: Dr. Wang (lfwyx@zju.edu.cn) and Dr. Li (lifengcheng@zju.edu.cn) -------------------------------------------------------------------------------------------------------- Abbreviations: DRUGNAME Drug Name DRUGTYPE Drug Type DISEASES Disease Entry DRUGSTAT Drug Status TARGNAME Target Name PCHEMCID PubChem_CID HIGHSTAT Drug Highest Status HIGHDISE Disease of Drug Highest Status -------------------------------------------------------------------------------------------------------- DRUG0233 DRUGNAME Remdesivir DRUG0233 DRUGTYPE Small molecular drug DRUG0233 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0233 DRUGSTAT Drug in Phase 3 Clinical Trial DRUG0233 TARGNAME COVID-19 RNA-directed RNA polymerase (RdRp) R1AB_SARS2 (RdRp) DRUG0233 PCHEMCID CID: 121304016 DRUG0234 DRUGNAME Favipiravir DRUG0234 DRUGTYPE Small molecular drug DRUG0234 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0234 DRUGSTAT Drug in Phase 3 Clinical Trial DRUG0234 TARGNAME COVID-19 RNA-directed RNA polymerase (RdRp) R1AB_SARS2 (RdRp) DRUG0234 PCHEMCID CID: 4424075 DRUG0234 HIGHSTAT Approved DRUG0234 HIGHDISE Influenza virus infection DRUG0191 DRUGNAME Baricitinib DRUG0191 DRUGTYPE Small molecular drug DRUG0191 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0191 DRUGSTAT Drug in Phase 3 Clinical Trial DRUG0191 TARGNAME HUMAN adaptor-associated kinase 1 (AAK1) AAK1_HUMAN DRUG0191 TARGNAME HUMAN cyclin G-associated kinase (GAK) GAK_HUMAN DRUG0191 PCHEMCID CID: 44205240 DRUG0191 HIGHSTAT Approved DRUG0191 HIGHDISE Rheumatoid arthritis DRUG0225 DRUGNAME Anakinra DRUG0225 DRUGTYPE Small molecular drug DRUG0225 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0225 DRUGSTAT Drug in Phase 3 Clinical Trial DRUG0225 TARGNAME HUMAN interleukin-1 receptor 1 (IL1R1) IL1R1_HUMAN DRUG0225 PCHEMCID CID: 139595263 DRUG0225 HIGHSTAT Approved DRUG0225 HIGHDISE Rheumatoid arthritis DRUG0202 DRUGNAME Ruxolitinib DRUG0202 DRUGTYPE Small molecular drug DRUG0202 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0202 DRUGSTAT Drug in Phase 3 Clinical Trial DRUG0202 TARGNAME HUMAN janus kinase 1 (JAK-1) JAK1_HUMAN DRUG0202 TARGNAME HUMAN janus kinase 2 (JAK-2) JAK2_HUMAN DRUG0202 PCHEMCID CID: 25126798 DRUG0202 HIGHSTAT Approved DRUG0202 HIGHDISE Myelofibrosis DRUG0205 DRUGNAME Isotretinoin DRUG0205 DRUGTYPE Small molecular drug DRUG0205 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0205 DRUGSTAT Drug in Phase 3 Clinical Trial DRUG0205 TARGNAME COVID-19 papain-like proteinase (PL-PRO) R1AB_SARS2 (PL-PRO) DRUG0205 PCHEMCID CID: 5282379 DRUG0189 DRUGNAME IMU-838 DRUG0189 DRUGTYPE Small molecular drug DRUG0189 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0189 DRUGSTAT Drug in Phase 2/3 Clinical Trial DRUG0189 TARGNAME HUMAN dihydroorotate dehydrogenase (DHODH) PYRD_HUMAN DRUG0189 PCHEMCID CID: 9820008 DRUG0172 DRUGNAME Nafamostat DRUG0172 DRUGTYPE Small molecular drug DRUG0172 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0172 DRUGSTAT Drug in Phase 2/3 Clinical Trial DRUG0172 TARGNAME COVID-19 spike glycoprotein (S) SPIKE_SARS2 DRUG0172 PCHEMCID CID: 4413 DRUG0242 DRUGNAME Captopril DRUG0242 DRUGTYPE Small molecular drug DRUG0242 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0242 DRUGSTAT Drug in Phase 3 Clinical Trial DRUG0242 TARGNAME HUMAN angiotensin-converting enzyme (ACE) ACE_HUMAN DRUG0242 PCHEMCID CID: 44093 DRUG0242 HIGHSTAT Approved DRUG0242 HIGHDISE Hypertension DRUG0238 DRUGNAME Telmisartan DRUG0238 DRUGTYPE Small molecular drug DRUG0238 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0238 DRUGSTAT Drug in Phase 3 Clinical Trial DRUG0238 TARGNAME HUMAN type-1 angiotensin II receptor (AGTR1) AGTR1_HUMAN DRUG0238 PCHEMCID CID: 65999 DRUG0238 HIGHSTAT Approved DRUG0238 HIGHDISE Hypertension DRUG0239 DRUGNAME Losartan DRUG0239 DRUGTYPE Small molecular drug DRUG0239 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0239 DRUGSTAT Drug in Phase 3 Clinical Trial DRUG0239 TARGNAME HUMAN type-1 angiotensin II receptor (AGTR1) AGTR1_HUMAN DRUG0239 PCHEMCID CID: 3961 DRUG0239 HIGHSTAT Approved DRUG0239 HIGHDISE Hypertension DRUG0245 DRUGNAME Linagliptin DRUG0245 DRUGTYPE Small molecular drug DRUG0245 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0245 DRUGSTAT Drug in Phase 3 Clinical Trial DRUG0245 TARGNAME HUMAN dipeptidyl peptidase 4 (DPP-4) DPP4_HUMAN DRUG0245 PCHEMCID CID: 10096344 DRUG0245 HIGHSTAT Approved DRUG0245 HIGHDISE Type 2 diabetes DRUG0231 DRUGNAME Sildenafil DRUG0231 DRUGTYPE Small molecular drug DRUG0231 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0231 DRUGSTAT Drug in Phase 3 Clinical Trial DRUG0231 TARGNAME HUMAN phosphodiesterase type 5 (PDE5) PDE5A_HUMAN DRUG0231 PCHEMCID CID: 135398744 DRUG0231 HIGHSTAT Approved DRUG0231 HIGHDISE Erectile dysfunction DRUG0185 DRUGNAME Verapamil DRUG0185 DRUGTYPE Small molecular drug DRUG0185 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0185 DRUGSTAT Drug in Phase 2/3 Clinical Trial DRUG0185 TARGNAME HUMAN two pore channel subtype 2 (TPC2) TPC2_HUMAN DRUG0185 PCHEMCID CID: 2520 DRUG0185 HIGHSTAT Approved DRUG0185 HIGHDISE High blood pressure DRUG0186 DRUGNAME Amiodarone DRUG0186 DRUGTYPE Small molecular drug DRUG0186 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0186 DRUGSTAT Drug in Phase 2/3 Clinical Trial DRUG0186 TARGNAME HUMAN two pore channel subtype 2 (TPC2) TPC2_HUMAN DRUG0186 PCHEMCID CID: 2157 DRUG0186 HIGHSTAT Approved DRUG0186 HIGHDISE Ventricular tachycardia DRUG0241 DRUGNAME Ramipril DRUG0241 DRUGTYPE Small molecular drug DRUG0241 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0241 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0241 TARGNAME HUMAN angiotensin-converting enzyme (ACE) ACE_HUMAN DRUG0241 PCHEMCID CID: 5362129 DRUG0241 HIGHSTAT Approved DRUG0241 HIGHDISE Heart failure DRUG0163 DRUGNAME Acalabrutinib DRUG0163 DRUGTYPE Small molecular drug DRUG0163 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0163 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0163 TARGNAME HUMAN bruton tyrosine kinase (BTK) BTK_HUMAN DRUG0163 PCHEMCID CID: 71226662 DRUG0163 HIGHSTAT Approved DRUG0163 HIGHDISE Leukemia DRUG0156 DRUGNAME BLD-2660 DRUG0156 DRUGTYPE Small molecular drug DRUG0156 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0156 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0156 TARGNAME HUMAN calpain-1/calpain small subunit 1 dimer (CAPN1/CAPNS1) CAN1_HUMAN/CPNS1_HUMAN DRUG0156 TARGNAME HUMAN calpain-2/calpain small subunit 1 dimer (CAPN2/CAPNS1) CAN2_HUMAN/CPNS1_HUMAN DRUG0169 DRUGNAME Sirolimus DRUG0169 DRUGTYPE Small molecular drug DRUG0169 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0169 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0169 TARGNAME HUMAN mammalian target of rapamycin (mTOR) MTOR_HUMAN DRUG0169 PCHEMCID CID: 5284616 DRUG0169 HIGHSTAT Approved DRUG0169 HIGHDISE Lymphangioleiomyomatosis DRUG0160 DRUGNAME Duvelisib DRUG0160 DRUGTYPE Small molecular drug DRUG0160 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0160 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0160 TARGNAME HUMAN PI3-kinase delta (PIK3CD) PK3CD_HUMAN DRUG0160 TARGNAME HUMAN PI3-kinase gamma (PIK3CG) PK3CG_HUMAN DRUG0160 PCHEMCID CID: 50905713 DRUG0160 HIGHSTAT Approved DRUG0160 HIGHDISE Follicular lymphoma DRUG0171 DRUGNAME Camostat mesylate DRUG0171 DRUGTYPE Small molecular drug DRUG0171 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0171 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0171 TARGNAME HUMAN transmembrane protease serine 2 (TMPRSS2) TMPS2_HUMAN DRUG0171 PCHEMCID CID: 5284360 DRUG0155 DRUGNAME Rintatolimod DRUG0155 DRUGTYPE Small molecular drug DRUG0155 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0155 DRUGSTAT Drug in Phase 1/2 Clinical Trial DRUG0155 TARGNAME HUMAN toll-like receptor 3 (TLR3) TLR3_HUMAN DRUG0155 PCHEMCID CID: 135537060 DRUG0155 HIGHSTAT Phase 3 DRUG0155 HIGHDISE Chronic Fatigue Syndrome DRUG0188 DRUGNAME Leflunomide DRUG0188 DRUGTYPE Small molecular drug DRUG0188 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0188 DRUGSTAT Drug in Phase 1 Clinical Trial DRUG0188 TARGNAME HUMAN dihydroorotate dehydrogenase (DHODH) PYRD_HUMAN DRUG0188 PCHEMCID CID: 3899 DRUG0188 HIGHSTAT Approved DRUG0188 HIGHDISE Multiple sclerosis DRUG0232 DRUGNAME Galidesivir DRUG0232 DRUGTYPE Small molecular drug DRUG0232 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0232 DRUGSTAT Drug in Phase 1 Clinical Trial DRUG0232 TARGNAME COVID-19 RNA-directed RNA polymerase (RdRp) R1AB_SARS2 (RdRp) DRUG0232 PCHEMCID CID: 69211190 DRUG0243 DRUGNAME Lisinopril DRUG0243 DRUGTYPE Small molecular drug DRUG0243 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0243 DRUGSTAT Investigative Agent DRUG0243 TARGNAME HUMAN angiotensin-converting enzyme (ACE) ACE_HUMAN DRUG0243 PCHEMCID CID: 5362119 DRUG0243 HIGHSTAT Approved DRUG0243 HIGHDISE Hypertension DRUG0255 DRUGNAME Carvedilol DRUG0255 DRUGTYPE Small molecular drug DRUG0255 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0255 DRUGSTAT Investigative Agent DRUG0255 TARGNAME HUMAN beta adrenergic receptor (BAR) ADRB1_HUMAN; ADRB2_HUMAN; ADRB3_HUMAN DRUG0255 PCHEMCID CID: 2585 DRUG0255 HIGHSTAT Approved DRUG0255 HIGHDISE Heart failure DRUG0240 DRUGNAME Irbesartan DRUG0240 DRUGTYPE Small molecular drug DRUG0240 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0240 DRUGSTAT Investigative Agent DRUG0240 TARGNAME HUMAN type-1 angiotensin II receptor (AGTR1) AGTR1_HUMAN DRUG0240 PCHEMCID CID: 3749 DRUG0240 HIGHSTAT Approved DRUG0240 HIGHDISE Hypertension DRUG0253 DRUGNAME JQ1 DRUG0253 DRUGTYPE Small molecular drug DRUG0253 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0253 DRUGSTAT Investigative Agent DRUG0253 TARGNAME HUMAN bromodomain-containing protein 2 (BRD2) BRD2_HUMAN DRUG0253 PCHEMCID CID: 46907787 DRUG0254 DRUGNAME ABBV-744 DRUG0254 DRUGTYPE Small molecular drug DRUG0254 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0254 DRUGSTAT Investigative Agent DRUG0254 TARGNAME HUMAN bromodomain-containing protein 2 (BRD2) BRD2_HUMAN DRUG0254 PCHEMCID CID: 132010322 DRUG0257 DRUGNAME Silmitasertib DRUG0257 DRUGTYPE Small molecular drug DRUG0257 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0257 DRUGSTAT Investigative Agent DRUG0257 TARGNAME HUMAN casein kinase II (CSK2) CSK21_HUMAN; CSK22_HUMAN; CSK23_HUMAN; CSK2B_HUMAN DRUG0257 PCHEMCID CID: 24748573 DRUG0257 HIGHSTAT Phase 1/2 DRUG0257 HIGHDISE Cholangiocarcinoma DRUG0152 DRUGNAME Ribavirin DRUG0152 DRUGTYPE Small molecular drug DRUG0152 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0152 DRUGSTAT Investigative Agent DRUG0152 TARGNAME HUMAN inosine-5'-monophosphate dehydrogenase 1 (IMPDH1) IMDH1_HUMAN DRUG0152 TARGNAME HUMAN inosine-5'-monophosphate dehydrogenase 2 (IMPDH2) IMDH2_HUMAN DRUG0152 PCHEMCID CID: 37542 DRUG0251 DRUGNAME Merimepodib DRUG0251 DRUGTYPE Small molecular drug DRUG0251 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0251 DRUGSTAT Investigative Agent DRUG0251 TARGNAME HUMAN inosine-5'-monophosphate dehydrogenase 2 (IMPDH2) IMDH2_HUMAN DRUG0251 PCHEMCID CID: 153241 DRUG0251 HIGHSTAT Phase 2b DRUG0251 HIGHDISE Hepatitis C virus infection DRUG0214 DRUGNAME Fedratinib DRUG0214 DRUGTYPE Small molecular drug DRUG0214 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0214 DRUGSTAT Investigative Agent DRUG0214 TARGNAME HUMAN janus kinase 2 (JAK-2) JAK2_HUMAN DRUG0214 PCHEMCID CID: 16722836 DRUG0214 HIGHSTAT Approved DRUG0214 HIGHDISE Polycythemia vera DRUG0252 DRUGNAME Metformin DRUG0252 DRUGTYPE Small molecular drug DRUG0252 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0252 DRUGSTAT Investigative Agent DRUG0252 TARGNAME HUMAN mannose receptor (MRC1) MRC1_HUMAN DRUG0252 PCHEMCID CID: 4091 DRUG0252 HIGHSTAT Approved DRUG0252 HIGHDISE Type 2 diabetes DRUG0170 DRUGNAME Sapanisertib DRUG0170 DRUGTYPE Small molecular drug DRUG0170 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0170 DRUGSTAT Investigative Agent DRUG0170 TARGNAME HUMAN mammalian target of rapamycin (mTOR) MTOR_HUMAN DRUG0170 PCHEMCID CID: 45375953 DRUG0170 HIGHSTAT Phase 2 DRUG0170 HIGHDISE Breast Cancer DRUG0235 DRUGNAME Suramin DRUG0235 DRUGTYPE Small molecular drug DRUG0235 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0235 DRUGSTAT Investigative Agent DRUG0235 TARGNAME COVID-19 RNA-directed RNA polymerase (RdRp) R1AB_SARS2 (RdRp) DRUG0235 PCHEMCID CID: 5361 DRUG0235 HIGHSTAT Phase 1 DRUG0235 HIGHDISE African trypanosomiasis DRUG0236 DRUGNAME Penciclovir DRUG0236 DRUGTYPE Small molecular drug DRUG0236 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0236 DRUGSTAT Investigative Agent DRUG0236 TARGNAME COVID-19 RNA-directed RNA polymerase (RdRp) R1AB_SARS2 (RdRp) DRUG0236 PCHEMCID CID: 135398748 DRUG0236 HIGHSTAT Approved DRUG0236 HIGHDISE Recurrent herpes labialis DRUG0237 DRUGNAME Anidulafungin DRUG0237 DRUGTYPE Small molecular drug DRUG0237 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0237 DRUGSTAT Investigative Agent DRUG0237 TARGNAME COVID-19 RNA-directed RNA polymerase (RdRp) R1AB_SARS2 (RdRp) DRUG0237 PCHEMCID CID: 166548 DRUG0237 HIGHSTAT Approved DRUG0237 HIGHDISE Candidiasis DRUG0206 DRUGNAME Tideglusib DRUG0206 DRUGTYPE Small molecular drug DRUG0206 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0206 DRUGSTAT Investigative Agent DRUG0206 TARGNAME COVID-19 papain-like proteinase (PL-PRO) R1AB_SARS2 (PL-PRO) DRUG0206 PCHEMCID CID: 11313622 DRUG0206 HIGHSTAT Phase 2 DRUG0206 HIGHDISE Alzheimer disease DRUG0207 DRUGNAME SPI-1005 DRUG0207 DRUGTYPE Small molecular drug DRUG0207 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0207 DRUGSTAT Investigative Agent DRUG0207 TARGNAME COVID-19 papain-like proteinase (PL-PRO) R1AB_SARS2 (PL-PRO) DRUG0207 PCHEMCID CID: 3194 DRUG0207 HIGHSTAT Phase 2b DRUG0207 HIGHDISE Meniere disease DRUG0208 DRUGNAME PX-12 DRUG0208 DRUGTYPE Small molecular drug DRUG0208 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0208 DRUGSTAT Investigative Agent DRUG0208 TARGNAME COVID-19 papain-like proteinase (PL-PRO) R1AB_SARS2 (PL-PRO) DRUG0208 HIGHSTAT Phase 2 DRUG0208 HIGHDISE Pancreatic cancer DRUG0209 DRUGNAME PMID32321856-compound-11b DRUG0209 DRUGTYPE Small molecular drug DRUG0209 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0209 DRUGSTAT Investigative Agent DRUG0209 TARGNAME COVID-19 papain-like proteinase (PL-PRO) R1AB_SARS2 (PL-PRO) DRUG0210 DRUGNAME PMID32321856-compound-11a DRUG0210 DRUGTYPE Small molecular drug DRUG0210 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0210 DRUGSTAT Investigative Agent DRUG0210 TARGNAME COVID-19 papain-like proteinase (PL-PRO) R1AB_SARS2 (PL-PRO) DRUG0176 DRUGNAME PMID26868298-compound-N3 DRUG0176 DRUGTYPE Small molecular drug DRUG0176 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0176 DRUGSTAT Investigative Agent DRUG0176 TARGNAME COVID-19 papain-like proteinase (PL-PRO) R1AB_SARS2 (PL-PRO) DRUG0211 DRUGNAME Isoarnebin 4 DRUG0211 DRUGTYPE Small molecular drug DRUG0211 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0211 DRUGSTAT Investigative Agent DRUG0211 TARGNAME COVID-19 papain-like proteinase (PL-PRO) R1AB_SARS2 (PL-PRO) DRUG0212 DRUGNAME Hexylcarbamoyl fluorouracil DRUG0212 DRUGTYPE Small molecular drug DRUG0212 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0212 DRUGSTAT Investigative Agent DRUG0212 TARGNAME COVID-19 papain-like proteinase (PL-PRO) R1AB_SARS2 (PL-PRO) DRUG0212 PCHEMCID CID: 2577 DRUG0213 DRUGNAME Disulfiram DRUG0213 DRUGTYPE Small molecular drug DRUG0213 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0213 DRUGSTAT Investigative Agent DRUG0213 TARGNAME COVID-19 papain-like proteinase (PL-PRO) R1AB_SARS2 (PL-PRO) DRUG0213 HIGHSTAT Approved DRUG0213 HIGHDISE Alcohol dependence DRUG0179 DRUGNAME GC376 DRUG0179 DRUGTYPE Small molecular drug DRUG0179 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0179 DRUGSTAT Investigative Agent DRUG0179 TARGNAME COVID-19 3C-like protease (3CLpro) R1AB_SARS2 (3CLpro) DRUG0179 PCHEMCID CID: 71481119 DRUG0223 DRUGNAME Boceprevir DRUG0223 DRUGTYPE Small molecular drug DRUG0223 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0223 DRUGSTAT Investigative Agent DRUG0223 TARGNAME COVID-19 3C-like protease (3CLpro) R1AB_SARS2 (3CLpro) DRUG0223 PCHEMCID CID: 10324367 DRUG0260 DRUGNAME PB28 DRUG0260 DRUGTYPE Small molecular drug DRUG0260 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0260 DRUGSTAT Investigative Agent DRUG0260 TARGNAME HUMAN opioid receptor sigma 1 (OPRS1) SGMR1_HUMAN DRUG0260 TARGNAME HUMAN sigma intracellular receptor 2 (TMEM97) SGMR2_HUMAN DRUG0261 DRUGNAME Haloperidol DRUG0261 DRUGTYPE Small molecular drug DRUG0261 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0261 DRUGSTAT Investigative Agent DRUG0261 TARGNAME HUMAN opioid receptor sigma 1 (OPRS1) SGMR1_HUMAN DRUG0261 TARGNAME HUMAN sigma intracellular receptor 2 (TMEM97) SGMR2_HUMAN DRUG0261 PCHEMCID CID: 3559 DRUG0261 HIGHSTAT Approved DRUG0261 HIGHDISE Schizophrenia DRUG0258 DRUGNAME RS-PPCC DRUG0258 DRUGTYPE Small molecular drug DRUG0258 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0258 DRUGSTAT Investigative Agent DRUG0258 TARGNAME HUMAN opioid receptor sigma 1 (OPRS1) SGMR1_HUMAN DRUG0259 DRUGNAME PD-144418 DRUG0259 DRUGTYPE Small molecular drug DRUG0259 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0259 DRUGSTAT Investigative Agent DRUG0259 TARGNAME HUMAN opioid receptor sigma 1 (OPRS1) SGMR1_HUMAN DRUG0259 PCHEMCID CID: 9817231 DRUG0262 DRUGNAME E-52862 DRUG0262 DRUGTYPE Small molecular drug DRUG0262 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0262 DRUGSTAT Investigative Agent DRUG0262 TARGNAME HUMAN opioid receptor sigma 1 (OPRS1) SGMR1_HUMAN DRUG0262 PCHEMCID CID: 44247568 DRUG0151 DRUGNAME NMS-873 DRUG0151 DRUGTYPE Small molecular drug DRUG0151 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0151 DRUGSTAT Investigative Agent DRUG0151 TARGNAME HUMAN valosin-containing protein p97 (VCP) TERA_HUMAN DRUG0151 PCHEMCID CID: 71521142 DRUG0227 DRUGNAME Ravulizumab DRUG0227 DRUGTYPE Monoclonal antibody DRUG0227 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0227 DRUGSTAT Drug in Phase 3 Clinical Trial DRUG0227 TARGNAME HUMAN complement C5 protein (C5) CO5_HUMAN DRUG0227 PCHEMCID SID: 363669767 DRUG0227 HIGHSTAT Approved DRUG0227 HIGHDISE Paroxysmal nocturnal hemoglobinuria DRUG0230 DRUGNAME Lenzilumab DRUG0230 DRUGTYPE Monoclonal antibody DRUG0230 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0230 DRUGSTAT Drug in Phase 3 Clinical Trial DRUG0230 TARGNAME HUMAN colony-stimulating factor (GM-CSF) CSF2_HUMAN DRUG0230 PCHEMCID SID: 310264716 DRUG0249 DRUGNAME Siltuximab DRUG0249 DRUGTYPE Monoclonal antibody DRUG0249 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0249 DRUGSTAT Drug in Phase 3 Clinical Trial DRUG0249 TARGNAME HUMAN interleukin 6 (IL6) IL6_HUMAN DRUG0249 PCHEMCID SID: 124490409 DRUG0249 HIGHSTAT Approved DRUG0249 HIGHDISE Idiopathic multicentric Castleman disease DRUG0203 DRUGNAME Tocilizumab DRUG0203 DRUGTYPE Monoclonal antibody DRUG0203 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0203 DRUGSTAT Drug in Phase 3 Clinical Trial DRUG0203 TARGNAME HUMAN interleukin-6 receptor (IL6R) IL6RA_HUMAN; IL6RB_HUMAN DRUG0203 HIGHSTAT Approved DRUG0203 HIGHDISE Giant cell arteritis DRUG0204 DRUGNAME Sarilumab DRUG0204 DRUGTYPE Monoclonal antibody DRUG0204 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0204 DRUGSTAT Drug in Phase 3 Clinical Trial DRUG0204 TARGNAME HUMAN interleukin-6 receptor (IL6R) IL6RA_HUMAN; IL6RB_HUMAN DRUG0204 HIGHSTAT Approved DRUG0204 HIGHDISE Rheumatoid arthritis DRUG0184 DRUGNAME IFX-1 DRUG0184 DRUGTYPE Monoclonal antibody DRUG0184 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0184 DRUGSTAT Drug in Phase 2/3 Clinical Trial DRUG0184 TARGNAME HUMAN complement C5 alpha (C5A) CO5_HUMAN (C5A) DRUG0184 PCHEMCID CID: 137254326 DRUG0183 DRUGNAME Emapalumab DRUG0183 DRUGTYPE Monoclonal antibody DRUG0183 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0183 DRUGSTAT Drug in Phase 2/3 Clinical Trial DRUG0183 TARGNAME HUMAN interferon gamma (IFNG) IFNG_HUMAN DRUG0183 PCHEMCID SID: 318164814 DRUG0183 HIGHSTAT Approved DRUG0183 HIGHDISE Primary haemophagocytic lymphohistiocytosis DRUG0248 DRUGNAME Olokizumab DRUG0248 DRUGTYPE Monoclonal antibody DRUG0248 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0248 DRUGSTAT Drug in Phase 2/3 Clinical Trial DRUG0248 TARGNAME HUMAN interleukin 6 (IL6) IL6_HUMAN DRUG0248 PCHEMCID SID: 160677293 DRUG0248 HIGHSTAT Phase 3 DRUG0248 HIGHDISE Rheumatoid Arthritis DRUG0190 DRUGNAME Bevacizumab DRUG0190 DRUGTYPE Monoclonal antibody DRUG0190 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0190 DRUGSTAT Drug in Phase 2/3 Clinical Trial DRUG0190 TARGNAME HUMAN vascular endothelial growth factor (VEGF) VEGFA_HUMAN; VEGFB_HUMAN; VEGFC_HUMAN; VEGFD_HUMAN DRUG0190 HIGHSTAT Approved DRUG0190 HIGHDISE Metastatic colorectal cancer DRUG0161 DRUGNAME LY3127804 DRUG0161 DRUGTYPE Monoclonal antibody DRUG0161 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0161 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0161 TARGNAME HUMAN angiopoietin-2 (ANG-2) ANGP2_HUMAN DRUG0162 DRUGNAME Avdoralimab DRUG0162 DRUGTYPE Monoclonal antibody DRUG0162 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0162 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0162 TARGNAME HUMAN C5a receptor (C5aR) C5AR1_HUMAN DRUG0164 DRUGNAME Leronlimab DRUG0164 DRUGTYPE Monoclonal antibody DRUG0164 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0164 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0164 TARGNAME HUMAN C-C chemokine receptor 5 (CCR5) CCR5_HUMAN DRUG0226 DRUGNAME Eculizumab DRUG0226 DRUGTYPE Monoclonal antibody DRUG0226 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0226 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0226 TARGNAME HUMAN complement C5 protein (C5) CO5_HUMAN DRUG0226 HIGHSTAT Approved DRUG0226 HIGHDISE Neuromyelitis optica DRUG0229 DRUGNAME Otilimab DRUG0229 DRUGTYPE Monoclonal antibody DRUG0229 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0229 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0229 TARGNAME HUMAN colony-stimulating factor (GM-CSF) CSF2_HUMAN DRUG0229 PCHEMCID SID: 381127828 DRUG0229 HIGHSTAT Phase 3 DRUG0229 HIGHDISE Rheumatoid arthritis DRUG0246 DRUGNAME Sirukumab DRUG0246 DRUGTYPE Monoclonal antibody DRUG0246 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0246 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0246 TARGNAME HUMAN interleukin 6 (IL6) IL6_HUMAN DRUG0246 PCHEMCID SID: 135626800 DRUG0246 HIGHSTAT Phase 3 DRUG0246 HIGHDISE Rheumatoid arthritis DRUG0247 DRUGNAME Clazakizumab DRUG0247 DRUGTYPE Monoclonal antibody DRUG0247 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0247 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0247 TARGNAME HUMAN interleukin 6 (IL6) IL6_HUMAN DRUG0247 PCHEMCID SID: 160671637 DRUG0159 DRUGNAME BMS-986253 DRUG0159 DRUGTYPE Monoclonal antibody DRUG0159 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0159 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0159 TARGNAME HUMAN interleukin 8 (IL8) IL8_HUMAN DRUG0159 PCHEMCID SID: 385157372 DRUG0153 DRUGNAME Meplazumab DRUG0153 DRUGTYPE Monoclonal antibody DRUG0153 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0153 DRUGSTAT Drug in Phase 1/2 Clinical Trial DRUG0153 TARGNAME HUMAN basigin (BSG) BASI_HUMAN DRUG0228 DRUGNAME TJ003234 DRUG0228 DRUGTYPE Monoclonal antibody DRUG0228 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0228 DRUGSTAT Drug in Phase 1/2 Clinical Trial DRUG0228 TARGNAME HUMAN colony-stimulating factor (GM-CSF) CSF2_HUMAN DRUG0166 DRUGNAME rhACE2 DRUG0166 DRUGTYPE Protein/peptide drug DRUG0166 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0166 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0166 TARGNAME HUMAN angiotensin-converting enzyme 2 (ACE2) ACE2_HUMAN DRUG0157 DRUGNAME PUL-042 DRUG0157 DRUGTYPE Protein/peptide drug DRUG0157 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0157 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0157 TARGNAME HUMAN toll-like receptor 2 (TLR2) TLR2_HUMAN DRUG0157 TARGNAME HUMAN toll-like receptor 6 (TLR6) TLR6_HUMAN DRUG0157 TARGNAME HUMAN toll-like receptor 9 (TLR9) TLR9_HUMAN DRUG0218 DRUGNAME Lopinavir + ritonavir + oseltamivir DRUG0218 DRUGTYPE Combination drug DRUG0218 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0218 DRUGSTAT Drug in Phase 3 Clinical Trial DRUG0218 TARGNAME COVID-19 3C-like protease (3CLpro) R1AB_SARS2 (3CLpro) DRUG0219 DRUGNAME Lopinavir + ritonavir + favipiravir DRUG0219 DRUGTYPE Combination drug DRUG0219 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0219 DRUGSTAT Drug in Phase 3 Clinical Trial DRUG0219 TARGNAME COVID-19 3C-like protease (3CLpro) R1AB_SARS2 (3CLpro) DRUG0220 DRUGNAME Lopinavir + ritonavir DRUG0220 DRUGTYPE Combination drug DRUG0220 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0220 DRUGSTAT Drug in Phase 3 Clinical Trial DRUG0220 TARGNAME COVID-19 3C-like protease (3CLpro) R1AB_SARS2 (3CLpro) DRUG0220 PCHEMCID CID: 11979606 DRUG0220 HIGHSTAT Approved DRUG0220 HIGHDISE Human immunodeficiency virus infection DRUG0221 DRUGNAME Darunavir + cobicistat DRUG0221 DRUGTYPE Combination drug DRUG0221 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0221 DRUGSTAT Drug in Phase 3 Clinical Trial DRUG0221 TARGNAME COVID-19 3C-like protease (3CLpro) R1AB_SARS2 (3CLpro) DRUG0222 DRUGNAME ASC09 + ritonavir + oseltamivir DRUG0222 DRUGTYPE Combination drug DRUG0222 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0222 DRUGSTAT Drug in Phase 3 Clinical Trial DRUG0222 TARGNAME COVID-19 3C-like protease (3CLpro) R1AB_SARS2 (3CLpro) DRUG0217 DRUGNAME Lopinavir + ritonavir + ribavirin + interferon beta-1b DRUG0217 DRUGTYPE Combination drug DRUG0217 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0217 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0217 TARGNAME COVID-19 RNA-directed RNA polymerase (RdRp) R1AB_SARS2 (RdRp) DRUG0217 TARGNAME COVID-19 3C-like protease (3CLpro) R1AB_SARS2 (3CLpro) DRUG0215 DRUGNAME Lopinavir + ritonavir + interferon apha + traditional Chinese Medicines granules DRUG0215 DRUGTYPE Combination drug DRUG0215 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0215 DRUGSTAT Drug in Phase 1 Clinical Trial DRUG0215 TARGNAME COVID-19 3C-like protease (3CLpro) R1AB_SARS2 (3CLpro) DRUG0216 DRUGNAME ASC09 + ritonavir DRUG0216 DRUGTYPE Combination drug DRUG0216 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0216 DRUGSTAT Drug in Phase 1 Clinical Trial DRUG0216 TARGNAME COVID-19 3C-like protease (3CLpro) R1AB_SARS2 (3CLpro) DRUG0224 DRUGNAME Lopinavir + ritonavir + interferon alpha DRUG0224 DRUGTYPE Combination drug DRUG0224 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0224 DRUGSTAT Preclinical Drug DRUG0224 TARGNAME COVID-19 3C-like protease (3CLpro) R1AB_SARS2 (3CLpro) DRUG0192 DRUGNAME Hydroxychloroquine DRUG0192 DRUGTYPE Small molecular drug DRUG0192 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0192 DRUGSTAT Drug in Phase 3 Clinical Trial DRUG0192 TARGNAME HUMAN toll-like receptor 7/9 signalling pathways (TLR7/9 pathway) N.A. DRUG0192 TARGNAME HUMAN pH-dependent viral fusion/replication (pH-DVF/R) N.A. DRUG0192 TARGNAME HUMAN glycosylation of host receptor (GHR) N.A. DRUG0192 PCHEMCID CID: 3652 DRUG0192 HIGHSTAT Approved DRUG0192 HIGHDISE Malaria DRUG0199 DRUGNAME Chlorpromazine DRUG0199 DRUGTYPE Small molecular drug DRUG0199 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0199 DRUGSTAT Drug in Phase 3 Clinical Trial DRUG0199 TARGNAME HUMAN clathrin-mediated endocytosis (RME) N.A. DRUG0199 PCHEMCID CID: 2726 DRUG0199 HIGHSTAT Withdrawn from market DRUG0199 HIGHDISE Schizophrenia DRUG0010 DRUGNAME Chloroquine DRUG0010 DRUGTYPE Small molecular drug DRUG0010 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0010 DRUGSTAT Drug in Phase 3 Clinical Trial DRUG0010 TARGNAME HUMAN pH-dependent viral fusion/replication (pH-DVF/R) N.A. DRUG0010 TARGNAME HUMAN glycosylation of host receptor (GHR) N.A. DRUG0010 PCHEMCID CID: 2719 DRUG0010 HIGHSTAT Withdrawn from market DRUG0010 HIGHDISE Malaria DRUG0158 DRUGNAME Atorvastatin DRUG0158 DRUGTYPE Small molecular drug DRUG0158 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0158 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0158 TARGNAME HUMAN MYD88-NF-kappa-B proinflammatory pathway (MYD88-NFKB pathway) N.A. DRUG0158 PCHEMCID CID: 60823 DRUG0158 HIGHSTAT Approved DRUG0158 HIGHDISE Hyperlipidemia DRUG0193 DRUGNAME Oseltamivir + hydroxychloroquine DRUG0193 DRUGTYPE Combination drug DRUG0193 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0193 DRUGSTAT Drug in Phase 3 Clinical Trial DRUG0193 TARGNAME HUMAN toll-like receptor 7/9 signalling pathways (TLR7/9 pathway) N.A. DRUG0193 TARGNAME HUMAN pH-dependent viral fusion/replication (pH-DVF/R) N.A. DRUG0193 TARGNAME HUMAN glycosylation of host receptor (GHR) N.A. DRUG0194 DRUGNAME Darunavir + ritonavir + oseltamivir + hydroxychloroquine DRUG0194 DRUGTYPE Combination drug DRUG0194 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0194 DRUGSTAT Drug in Phase 3 Clinical Trial DRUG0194 TARGNAME HUMAN toll-like receptor 7/9 signalling pathways (TLR7/9 pathway) N.A. DRUG0194 TARGNAME HUMAN pH-dependent viral fusion/replication (pH-DVF/R) N.A. DRUG0194 TARGNAME HUMAN glycosylation of host receptor (GHR) N.A. DRUG0195 DRUGNAME Darunavir + ritonavir + favipiravir + hydroxychloroquine DRUG0195 DRUGTYPE Combination drug DRUG0195 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0195 DRUGSTAT Drug in Phase 3 Clinical Trial DRUG0195 TARGNAME HUMAN toll-like receptor 7/9 signalling pathways (TLR7/9 pathway) N.A. DRUG0195 TARGNAME HUMAN pH-dependent viral fusion/replication (pH-DVF/R) N.A. DRUG0195 TARGNAME HUMAN glycosylation of host receptor (GHR) N.A. DRUG0196 DRUGNAME Azithromycin + hydroxychloroquine DRUG0196 DRUGTYPE Combination drug DRUG0196 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0196 DRUGSTAT Drug in Phase 3 Clinical Trial DRUG0196 TARGNAME HUMAN toll-like receptor 7/9 signalling pathways (TLR7/9 pathway) N.A. DRUG0196 TARGNAME HUMAN pH-dependent viral fusion/replication (pH-DVF/R) N.A. DRUG0196 TARGNAME HUMAN glycosylation of host receptor (GHR) N.A. DRUG0172 DRUGNAME Nafamostat DRUG0172 DRUGTYPE Small molecular drug DRUG0172 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0172 DRUGSTAT Preclinical Drug DRUG0172 TARGNAME MERS-CoV spike glycoprotein (S) A0A140AYZ5_9BETC DRUG0172 PCHEMCID CID: 4413 DRUG0302 DRUGNAME PMID26868298-compound-5705213 DRUG0302 DRUGTYPE Small molecular drug DRUG0302 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0302 DRUGSTAT Preclinical Drug DRUG0302 TARGNAME HUMAN cathepsin L (CTSL) CATL1_HUMAN DRUG0303 DRUGNAME K11777 DRUG0303 DRUGTYPE Small molecular drug DRUG0303 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0303 DRUGSTAT Preclinical Drug DRUG0303 TARGNAME HUMAN cathepsin L (CTSL) CATL1_HUMAN DRUG0301 DRUGNAME E-64D DRUG0301 DRUGTYPE Small molecular drug DRUG0301 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0301 DRUGSTAT Preclinical Drug DRUG0301 TARGNAME HUMAN cathepsin L (CTSL) CATL1_HUMAN DRUG0301 PCHEMCID CID: 65663 DRUG0187 DRUGNAME FA-613 DRUG0187 DRUGTYPE Small molecular drug DRUG0187 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0187 DRUGSTAT Preclinical Drug DRUG0187 TARGNAME HUMAN dihydroorotate dehydrogenase (DHODH) PYRD_HUMAN DRUG0289 DRUGNAME PMID26048809-compound2 DRUG0289 DRUGTYPE Small molecular drug DRUG0289 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0289 DRUGSTAT Preclinical Drug DRUG0289 TARGNAME MERS-CoV RNA-directed RNA polymerase (RdRp) R1AB_CVEMC (RdRp) DRUG0232 DRUGNAME Galidesivir DRUG0232 DRUGTYPE Small molecular drug DRUG0232 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0232 DRUGSTAT Preclinical Drug DRUG0232 TARGNAME MERS-CoV RNA-directed RNA polymerase (RdRp) R1AB_CVEMC (RdRp) DRUG0232 PCHEMCID CID: 69211190 DRUG0290 DRUGNAME PMID31244113-compound-2c DRUG0290 DRUGTYPE Small molecular drug DRUG0290 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0290 DRUGSTAT Preclinical Drug DRUG0290 TARGNAME MERS-CoV RNA-directed RNA polymerase (RdRp) R1AB_CVEMC (RdRp) DRUG0271 DRUGNAME Thioguanine DRUG0271 DRUGTYPE Small molecular drug DRUG0271 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0271 DRUGSTAT Preclinical Drug DRUG0271 TARGNAME MERS-CoV papain-like proteinase (PL-PRO) R1AB_CVEMC (PL-PRO) DRUG0271 PCHEMCID CID: 2723601 DRUG0271 HIGHSTAT Approved DRUG0271 HIGHDISE Acute lymphocytic leukaemia DRUG0272 DRUGNAME Mercaptopurine DRUG0272 DRUGTYPE Small molecular drug DRUG0272 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0272 DRUGSTAT Preclinical Drug DRUG0272 TARGNAME MERS-CoV papain-like proteinase (PL-PRO) R1AB_CVEMC (PL-PRO) DRUG0272 PCHEMCID CID: 667490 DRUG0272 HIGHSTAT Approved DRUG0272 HIGHDISE Acute lymphocytic leukaemia DRUG0273 DRUGNAME PMID30940566-compound-6 DRUG0273 DRUGTYPE Small molecular drug DRUG0273 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0273 DRUGSTAT Preclinical Drug DRUG0273 TARGNAME MERS-CoV papain-like proteinase (PL-PRO) R1AB_CVEMC (PL-PRO) DRUG0283 DRUGNAME SSYA10-001 DRUG0283 DRUGTYPE Small molecular drug DRUG0283 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0283 DRUGSTAT Preclinical Drug DRUG0283 TARGNAME MERS-CoV helicase (Hel) R1AB_CVEMC (Hel) DRUG0284 DRUGNAME PMID31955138-compound-16 DRUG0284 DRUGTYPE Small molecular drug DRUG0284 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0284 DRUGSTAT Preclinical Drug DRUG0284 TARGNAME MERS-CoV helicase (Hel) R1AB_CVEMC (Hel) DRUG0176 DRUGNAME PMID26868298-compound-N3 DRUG0176 DRUGTYPE Small molecular drug DRUG0176 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0176 DRUGSTAT Preclinical Drug DRUG0176 TARGNAME MERS-CoV 3C-like proteinase (3CLpro) R1AB_CVEMC (3CLpro) DRUG0177 DRUGNAME GRL-001 DRUG0177 DRUGTYPE Small molecular drug DRUG0177 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0177 DRUGSTAT Preclinical Drug DRUG0177 TARGNAME MERS-CoV 3C-like proteinase (3CLpro) R1AB_CVEMC (3CLpro) DRUG0178 DRUGNAME Lopinavir DRUG0178 DRUGTYPE Small molecular drug DRUG0178 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0178 DRUGSTAT Preclinical Drug DRUG0178 TARGNAME MERS-CoV 3C-like proteinase (3CLpro) R1AB_CVEMC (3CLpro) DRUG0178 PCHEMCID CID: 92727 DRUG0178 HIGHSTAT Approved DRUG0178 HIGHDISE Human immunodeficiency virus infection DRUG0179 DRUGNAME GC376 DRUG0179 DRUGTYPE Small molecular drug DRUG0179 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0179 DRUGSTAT Preclinical Drug DRUG0179 TARGNAME MERS-CoV 3C-like proteinase (3CLpro) R1AB_CVEMC (3CLpro) DRUG0179 PCHEMCID CID: 71481119 DRUG0180 DRUGNAME PMID27240464-compound-3f DRUG0180 DRUGTYPE Small molecular drug DRUG0180 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0180 DRUGSTAT Preclinical Drug DRUG0180 TARGNAME MERS-CoV 3C-like proteinase (3CLpro) R1AB_CVEMC (3CLpro) DRUG0181 DRUGNAME PMID28216367-compound-6d DRUG0181 DRUGTYPE Small molecular drug DRUG0181 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0181 DRUGSTAT Preclinical Drug DRUG0181 TARGNAME MERS-CoV 3C-like proteinase (3CLpro) R1AB_CVEMC (3CLpro) DRUG0182 DRUGNAME GC813 DRUG0182 DRUGTYPE Small molecular drug DRUG0182 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0182 DRUGSTAT Preclinical Drug DRUG0182 TARGNAME MERS-CoV 3C-like proteinase (3CLpro) R1AB_CVEMC (3CLpro) DRUG0268 DRUGNAME Acocantherin DRUG0268 DRUGTYPE Small molecular drug DRUG0268 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0268 DRUGSTAT Investigative Agent DRUG0268 TARGNAME HUMAN sodium pump subunit alpha-1 (ATP1A1) AT1A1_HUMAN DRUG0268 PCHEMCID CID: 439501 DRUG0125 DRUGNAME Imatinib DRUG0125 DRUGTYPE Small molecular drug DRUG0125 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0125 DRUGSTAT Investigative Agent DRUG0125 TARGNAME HUMAN fusion protein Bcr-Abl (Bcr-Abl) BCR_HUMAN-ABL1_HUMAN DRUG0125 PCHEMCID CID: 5291 DRUG0125 HIGHSTAT Approved DRUG0125 HIGHDISE Chronic myeloid leukaemia DRUG0267 DRUGNAME Dasatinib DRUG0267 DRUGTYPE Small molecular drug DRUG0267 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0267 DRUGSTAT Investigative Agent DRUG0267 TARGNAME HUMAN fusion protein Bcr-Abl (Bcr-Abl) BCR_HUMAN-ABL1_HUMAN DRUG0267 PCHEMCID CID: 3062316 DRUG0267 HIGHSTAT Approved DRUG0267 HIGHDISE Chronic myeloid leukaemia DRUG0256 DRUGNAME Silvestrol DRUG0256 DRUGTYPE Small molecular drug DRUG0256 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0256 DRUGSTAT Investigative Agent DRUG0256 TARGNAME HUMAN eukaryotic initiation factor-4A (eIF4A) IF4A1_HUMAN; IF4A2_HUMAN; IF4A3_HUMAN DRUG0256 PCHEMCID CID: 11787114 DRUG0266 DRUGNAME Trametinib DRUG0266 DRUGTYPE Small molecular drug DRUG0266 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0266 DRUGSTAT Investigative Agent DRUG0266 TARGNAME HUMAN ERK activator kinase 1 (MEK1) MP2K1_HUMAN DRUG0266 TARGNAME HUMAN ERK activator kinase 2 (MEK2) MP2K2_HUMAN DRUG0266 PCHEMCID CID: 11707110 DRUG0266 HIGHSTAT Approved DRUG0266 HIGHDISE Metastatic melanoma DRUG0265 DRUGNAME Selumetinib DRUG0265 DRUGTYPE Small molecular drug DRUG0265 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0265 DRUGSTAT Investigative Agent DRUG0265 TARGNAME HUMAN ERK activator kinase 1 (MEK1) MP2K1_HUMAN DRUG0265 TARGNAME HUMAN ERK activator kinase 2 (MEK2) MP2K2_HUMAN DRUG0265 PCHEMCID CID: 10127622 DRUG0265 HIGHSTAT Approved DRUG0265 HIGHDISE Neurofibromatosis type 1 DRUG0167 DRUGNAME Rapamycin DRUG0167 DRUGTYPE Small molecular drug DRUG0167 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0167 DRUGSTAT Investigative Agent DRUG0167 TARGNAME HUMAN mammalian target of rapamycin (mTOR) MTOR_HUMAN DRUG0167 PCHEMCID CID: 6436030 DRUG0167 HIGHSTAT Approved DRUG0167 HIGHDISE Lymphangioleiomyomatosis DRUG0168 DRUGNAME Everolimus DRUG0168 DRUGTYPE Small molecular drug DRUG0168 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0168 DRUGSTAT Investigative Agent DRUG0168 TARGNAME HUMAN mammalian target of rapamycin (mTOR) MTOR_HUMAN DRUG0168 PCHEMCID CID: 6442177 DRUG0168 HIGHSTAT Approved DRUG0168 HIGHDISE Advanced/metastatic breast cancer DRUG0152 DRUGNAME Ribavirin DRUG0152 DRUGTYPE Small molecular drug DRUG0152 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0152 DRUGSTAT Investigative Agent DRUG0152 TARGNAME MERS-CoV RNA-directed RNA polymerase (RdRp) R1AB_CVEMC (RdRp) DRUG0152 PCHEMCID CID: 37542 DRUG0152 HIGHSTAT Approved DRUG0152 HIGHDISE Hepatitis C virus infection DRUG0285 DRUGNAME Amarylline DRUG0285 DRUGTYPE Small molecular drug DRUG0285 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0285 DRUGSTAT Investigative Agent DRUG0285 TARGNAME MERS-CoV RNA-directed RNA polymerase (RdRp) R1AB_CVEMC (RdRp) DRUG0285 PCHEMCID CID: 72378 DRUG0233 DRUGNAME Remdesivir DRUG0233 DRUGTYPE Small molecular drug DRUG0233 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0233 DRUGSTAT Investigative Agent DRUG0233 TARGNAME MERS-CoV RNA-directed RNA polymerase (RdRp) R1AB_CVEMC (RdRp) DRUG0233 PCHEMCID CID: 121304016 DRUG0270 DRUGNAME Mycophenolic acid DRUG0270 DRUGTYPE Small molecular drug DRUG0270 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0270 DRUGSTAT Investigative Agent DRUG0270 TARGNAME MERS-CoV papain-like proteinase (PL-PRO) R1AB_CVEMC (PL-PRO) DRUG0270 PCHEMCID CID: 446541 DRUG0270 HIGHSTAT Approved DRUG0270 HIGHDISE Crohn disease DRUG0213 DRUGNAME Disulfiram DRUG0213 DRUGTYPE Small molecular drug DRUG0213 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0213 DRUGSTAT Investigative Agent DRUG0213 TARGNAME MERS-CoV papain-like proteinase (PL-PRO) R1AB_CVEMC (PL-PRO) DRUG0213 PCHEMCID CID: 3117 DRUG0213 HIGHSTAT Approved DRUG0213 HIGHDISE Alcohol dependence DRUG0154 DRUGNAME Polyinosinic:polycytidylic acid DRUG0154 DRUGTYPE Small molecular drug DRUG0154 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0154 DRUGSTAT Investigative Agent DRUG0154 TARGNAME HUMAN toll-like receptor 3 (TLR3) TLR3_HUMAN DRUG0154 PCHEMCID CID: 135478809 DRUG0171 DRUGNAME Camostat mesylate DRUG0171 DRUGTYPE Small molecular drug DRUG0171 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0171 DRUGSTAT Investigative Agent DRUG0171 TARGNAME HUMAN transmembrane protease serine 2 (TMPRSS2) TMPS2_HUMAN DRUG0171 PCHEMCID CID: 5284360 DRUG0244 DRUGNAME YS110 mAb clone DRUG0244 DRUGTYPE Monoclonal antibody DRUG0244 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0244 DRUGSTAT Investigative Agent DRUG0244 TARGNAME HUMAN dipeptidyl peptidase 4 (DPP-4) DPP4_HUMAN DRUG0274 DRUGNAME REGN 3048 DRUG0274 DRUGTYPE Monoclonal antibody DRUG0274 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0274 DRUGSTAT Discontinue Drug in Phase 1 Clinical Trial DRUG0274 TARGNAME MERS-CoV spike glycoprotein (S) A0A140AYZ5_9BETC DRUG0275 DRUGNAME REGN 3051 DRUG0275 DRUGTYPE Monoclonal antibody DRUG0275 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0275 DRUGSTAT Discontinue Drug in Phase 1 Clinical Trial DRUG0275 TARGNAME MERS-CoV spike glycoprotein (S) A0A140AYZ5_9BETC DRUG0297 DRUGNAME HR2P-M2 peptide DRUG0297 DRUGTYPE Protein/peptide drug DRUG0297 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0297 DRUGSTAT Preclinical Drug DRUG0297 TARGNAME MERS-CoV spike glycoprotein S2 subunit (S S2) A0A140AYZ5_9BETC (S2) DRUG0298 DRUGNAME HR2P peptide DRUG0298 DRUGTYPE Protein/peptide drug DRUG0298 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0298 DRUGSTAT Preclinical Drug DRUG0298 TARGNAME MERS-CoV spike glycoprotein S2 subunit (S S2) A0A140AYZ5_9BETC (S2) DRUG0299 DRUGNAME HR1P peptide DRUG0299 DRUGTYPE Protein/peptide drug DRUG0299 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0299 DRUGSTAT Preclinical Drug DRUG0299 TARGNAME MERS-CoV spike glycoprotein S2 subunit (S S2) A0A140AYZ5_9BETC (S2) DRUG0300 DRUGNAME HR2P-M1 peptide DRUG0300 DRUGTYPE Protein/peptide drug DRUG0300 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0300 DRUGSTAT Preclinical Drug DRUG0300 TARGNAME MERS-CoV spike glycoprotein S2 subunit (S S2) A0A140AYZ5_9BETC (S2) DRUG0276 DRUGNAME PMID26911565-peptide-P9 DRUG0276 DRUGTYPE Protein/peptide drug DRUG0276 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0276 DRUGSTAT Preclinical Drug DRUG0276 TARGNAME MERS-CoV spike glycoprotein (S) A0A140AYZ5_9BETC DRUG0277 DRUGNAME MERS-five-helix bundle DRUG0277 DRUGTYPE Protein/peptide drug DRUG0277 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0277 DRUGSTAT Preclinical Drug DRUG0277 TARGNAME MERS-CoV spike glycoprotein (S) A0A140AYZ5_9BETC DRUG0278 DRUGNAME Peptide P21S10 DRUG0278 DRUGTYPE Protein/peptide drug DRUG0278 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0278 DRUGSTAT Preclinical Drug DRUG0278 TARGNAME MERS-CoV spike glycoprotein (S) A0A140AYZ5_9BETC DRUG0279 DRUGNAME Alpha-Helical lipopeptides LLS DRUG0279 DRUGTYPE Protein/peptide drug DRUG0279 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0279 DRUGSTAT Preclinical Drug DRUG0279 TARGNAME MERS-CoV spike glycoprotein (S) A0A140AYZ5_9BETC DRUG0280 DRUGNAME Alpha-Helical lipopeptides IIS DRUG0280 DRUGTYPE Protein/peptide drug DRUG0280 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0280 DRUGSTAT Preclinical Drug DRUG0280 TARGNAME MERS-CoV spike glycoprotein (S) A0A140AYZ5_9BETC DRUG0281 DRUGNAME Alpha-Helical lipopeptides IIK DRUG0281 DRUGTYPE Protein/peptide drug DRUG0281 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0281 DRUGSTAT Preclinical Drug DRUG0281 TARGNAME MERS-CoV spike glycoprotein (S) A0A140AYZ5_9BETC DRUG0282 DRUGNAME Alpha-Helical lipopeptides FFS DRUG0282 DRUGTYPE Protein/peptide drug DRUG0282 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0282 DRUGSTAT Preclinical Drug DRUG0282 TARGNAME MERS-CoV spike glycoprotein (S) A0A140AYZ5_9BETC DRUG0304 DRUGNAME Dec-RVKR-CMK DRUG0304 DRUGTYPE Protein/peptide drug DRUG0304 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0304 DRUGSTAT Preclinical Drug DRUG0304 TARGNAME HUMAN dibasic-processing enzyme (Furin) FURIN_HUMAN DRUG0304 PCHEMCID CID: 9962075 DRUG0250 DRUGNAME Fusion peptide EK1 DRUG0250 DRUGTYPE Protein/peptide drug DRUG0250 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0250 DRUGSTAT Investigative Agent DRUG0250 TARGNAME MERS-CoV spike glycoprotein S2' HR1 region (S S2'HR1) A0A140AYZ5_9BETC (S2'HR1) DRUG0264 DRUGNAME Alisporivir DRUG0264 DRUGTYPE Protein/peptide drug DRUG0264 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0264 DRUGSTAT Investigative Agent DRUG0264 TARGNAME HUMAN cyclophilin A (CYPA) PPIA_HUMAN DRUG0264 PCHEMCID CID: 11513676 DRUG0264 HIGHSTAT Phase 3 DRUG0264 HIGHDISE Hepatitis C virus infection DRUG0263 DRUGNAME Ciclosporin DRUG0263 DRUGTYPE Protein/peptide drug DRUG0263 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0263 DRUGSTAT Investigative Agent DRUG0263 TARGNAME HUMAN cyclophilin D (CYP3) PPIF_HUMAN DRUG0263 PCHEMCID CID: 24883466 DRUG0263 HIGHSTAT Approved DRUG0263 HIGHDISE Graft-versus-host disease DRUG0173 DRUGNAME Lopinavir + ritonavir + interferon beta-1b DRUG0173 DRUGTYPE Combination drug DRUG0173 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0173 DRUGSTAT Drug in Phase 2/3 Clinical Trial DRUG0173 TARGNAME MERS-CoV 3C-like proteinase (3CLpro) R1AB_CVEMC (3CLpro) DRUG0286 DRUGNAME Ribavirin + interferon alfa-2a DRUG0286 DRUGTYPE Combination drug DRUG0286 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0286 DRUGSTAT Investigative Agent DRUG0286 TARGNAME MERS-CoV RNA-directed RNA polymerase (RdRp) R1AB_CVEMC (RdRp) DRUG0287 DRUGNAME Ribavirin + interferon alfa-2b DRUG0287 DRUGTYPE Combination drug DRUG0287 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0287 DRUGSTAT Investigative Agent DRUG0287 TARGNAME MERS-CoV RNA-directed RNA polymerase (RdRp) R1AB_CVEMC (RdRp) DRUG0288 DRUGNAME Ribavirin + interferon beta-1a DRUG0288 DRUGTYPE Combination drug DRUG0288 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0288 DRUGSTAT Investigative Agent DRUG0288 TARGNAME MERS-CoV RNA-directed RNA polymerase (RdRp) R1AB_CVEMC (RdRp) DRUG0174 DRUGNAME Ribavirin + lopinavir + ritonavir + interferon alfa-2a DRUG0174 DRUGTYPE Combination drug DRUG0174 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0174 DRUGSTAT Investigative Agent DRUG0174 TARGNAME MERS-CoV RNA-directed RNA polymerase (RdRp) R1AB_CVEMC (RdRp) DRUG0174 TARGNAME MERS-CoV 3C-like proteinase (3CLpro) R1AB_CVEMC (3CLpro) DRUG0175 DRUGNAME Lopinavir + ritonavir + interferon beta DRUG0175 DRUGTYPE Combination drug DRUG0175 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0175 DRUGSTAT Investigative Agent DRUG0175 TARGNAME MERS-CoV 3C-like proteinase (3CLpro) R1AB_CVEMC (3CLpro) DRUG0197 DRUGNAME Triflupromazine DRUG0197 DRUGTYPE Small molecular drug DRUG0197 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0197 DRUGSTAT Investigative Agent DRUG0197 TARGNAME HUMAN clathrin-mediated endocytosis (RME) N.A. DRUG0197 PCHEMCID CID: 5568 DRUG0197 HIGHSTAT Withdrawn from market DRUG0197 HIGHDISE Schizophrenia DRUG0200 DRUGNAME Promethazine DRUG0200 DRUGTYPE Small molecular drug DRUG0200 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0200 DRUGSTAT Investigative Agent DRUG0200 TARGNAME HUMAN clathrin-mediated endocytosis (RME) N.A. DRUG0200 PCHEMCID CID: 4927 DRUG0198 DRUGNAME Fluphenazine DRUG0198 DRUGTYPE Small molecular drug DRUG0198 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0198 DRUGSTAT Investigative Agent DRUG0198 TARGNAME HUMAN clathrin-mediated endocytosis (RME) N.A. DRUG0198 PCHEMCID CID: 3372 DRUG0199 DRUGNAME Chlorpromazine DRUG0199 DRUGTYPE Small molecular drug DRUG0199 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0199 DRUGSTAT Investigative Agent DRUG0199 TARGNAME HUMAN clathrin-mediated endocytosis (RME) N.A. DRUG0199 PCHEMCID CID: 2726 DRUG0199 HIGHSTAT Withdrawn from market DRUG0199 HIGHDISE Schizophrenia DRUG0201 DRUGNAME Thiethylperazine DRUG0201 DRUGTYPE Small molecular drug DRUG0201 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0201 DRUGSTAT Investigative Agent DRUG0201 TARGNAME HUMAN clathrin-mediated endocytosis (RME) N.A. DRUG0201 PCHEMCID CID: 5440 DRUG0303 DRUGNAME K11777 DRUG0303 DRUGTYPE Small molecular drug DRUG0303 DISEASES Severe acute respiratory syndrome (SARS) DRUG0303 DRUGSTAT Preclinical Drug DRUG0303 TARGNAME HUMAN cathepsin L (CTSL) CATL1_HUMAN DRUG0301 DRUGNAME E-64D DRUG0301 DRUGTYPE Small molecular drug DRUG0301 DISEASES Severe acute respiratory syndrome (SARS) DRUG0301 DRUGSTAT Preclinical Drug DRUG0301 TARGNAME HUMAN cathepsin L (CTSL) CATL1_HUMAN DRUG0301 PCHEMCID CID: 65663 DRUG0187 DRUGNAME FA-613 DRUG0187 DRUGTYPE Small molecular drug DRUG0187 DISEASES Severe acute respiratory syndrome (SARS) DRUG0187 DRUGSTAT Preclinical Drug DRUG0187 TARGNAME HUMAN dihydroorotate dehydrogenase (DHODH) PYRD_HUMAN DRUG0232 DRUGNAME Galidesivir DRUG0232 DRUGTYPE Small molecular drug DRUG0232 DISEASES Severe acute respiratory syndrome (SARS) DRUG0232 DRUGSTAT Preclinical Drug DRUG0232 TARGNAME SARS-CoV RNA-directed RNA polymerase (RdRp) R1AB_CVHSA (RdRp) DRUG0232 PCHEMCID CID: 69211190 DRUG0271 DRUGNAME Thioguanine DRUG0271 DRUGTYPE Small molecular drug DRUG0271 DISEASES Severe acute respiratory syndrome (SARS) DRUG0271 DRUGSTAT Preclinical Drug DRUG0271 TARGNAME SARS-CoV papain-like proteinase (PL-PRO) R1AB_CVHSA (PL-PRO) DRUG0271 PCHEMCID CID: 2723601 DRUG0271 HIGHSTAT Approved DRUG0271 HIGHDISE Acute lymphocytic leukaemia DRUG0272 DRUGNAME Mercaptopurine DRUG0272 DRUGTYPE Small molecular drug DRUG0272 DISEASES Severe acute respiratory syndrome (SARS) DRUG0272 DRUGSTAT Preclinical Drug DRUG0272 TARGNAME SARS-CoV papain-like proteinase (PL-PRO) R1AB_CVHSA (PL-PRO) DRUG0272 PCHEMCID CID: 667490 DRUG0272 HIGHSTAT Approved DRUG0272 HIGHDISE Acute lymphocytic leukaemia DRUG0302 DRUGNAME PMID26868298-compound-5705213 DRUG0302 DRUGTYPE Small molecular drug DRUG0302 DISEASES Severe acute respiratory syndrome (SARS) DRUG0302 DRUGSTAT Preclinical Drug DRUG0302 TARGNAME HUMAN cathepsin L (CTSL) CATL1_HUMAN DRUG0290 DRUGNAME PMID31244113-compound-2c DRUG0290 DRUGTYPE Small molecular drug DRUG0290 DISEASES Severe acute respiratory syndrome (SARS) DRUG0290 DRUGSTAT Preclinical Drug DRUG0290 TARGNAME SARS-CoV RNA-directed RNA polymerase (RdRp) R1AB_CVHSA (RdRp) DRUG0296 DRUGNAME PMID21925774-compound-5e DRUG0296 DRUGTYPE Small molecular drug DRUG0296 DISEASES Severe acute respiratory syndrome (SARS) DRUG0296 DRUGSTAT Preclinical Drug DRUG0296 TARGNAME SARS-CoV helicase (Hel) R1AB_CVHSA (Hel) DRUG0283 DRUGNAME SSYA10-001 DRUG0283 DRUGTYPE Small molecular drug DRUG0283 DISEASES Severe acute respiratory syndrome (SARS) DRUG0283 DRUGSTAT Preclinical Drug DRUG0283 TARGNAME SARS-CoV helicase (Hel) R1AB_CVHSA (Hel) DRUG0176 DRUGNAME PMID26868298-compound-N3 DRUG0176 DRUGTYPE Small molecular drug DRUG0176 DISEASES Severe acute respiratory syndrome (SARS) DRUG0176 DRUGSTAT Preclinical Drug DRUG0176 TARGNAME SARS-CoV 3C-like protease (3CLpro) R1AB_CVHSA (3CLpro) DRUG0177 DRUGNAME GRL-001 DRUG0177 DRUGTYPE Small molecular drug DRUG0177 DISEASES Severe acute respiratory syndrome (SARS) DRUG0177 DRUGSTAT Preclinical Drug DRUG0177 TARGNAME SARS-CoV 3C-like protease (3CLpro) R1AB_CVHSA (3CLpro) DRUG0178 DRUGNAME Lopinavir DRUG0178 DRUGTYPE Small molecular drug DRUG0178 DISEASES Severe acute respiratory syndrome (SARS) DRUG0178 DRUGSTAT Preclinical Drug DRUG0178 TARGNAME SARS-CoV 3C-like protease (3CLpro) R1AB_CVHSA (3CLpro) DRUG0178 PCHEMCID CID: 92727 DRUG0178 HIGHSTAT Approved DRUG0178 HIGHDISE Human immunodeficiency virus infection DRUG0179 DRUGNAME GC376 DRUG0179 DRUGTYPE Small molecular drug DRUG0179 DISEASES Severe acute respiratory syndrome (SARS) DRUG0179 DRUGSTAT Preclinical Drug DRUG0179 TARGNAME SARS-CoV 3C-like protease (3CLpro) R1AB_CVHSA (3CLpro) DRUG0179 PCHEMCID CID: 71481119 DRUG0180 DRUGNAME PMID27240464-compound-3f DRUG0180 DRUGTYPE Small molecular drug DRUG0180 DISEASES Severe acute respiratory syndrome (SARS) DRUG0180 DRUGSTAT Preclinical Drug DRUG0180 TARGNAME SARS-CoV 3C-like protease (3CLpro) R1AB_CVHSA (3CLpro) DRUG0181 DRUGNAME PMID28216367-compound-6d DRUG0181 DRUGTYPE Small molecular drug DRUG0181 DISEASES Severe acute respiratory syndrome (SARS) DRUG0181 DRUGSTAT Preclinical Drug DRUG0181 TARGNAME SARS-CoV 3C-like protease (3CLpro) R1AB_CVHSA (3CLpro) DRUG0293 DRUGNAME Phenylisoserine derivatives SK80 DRUG0293 DRUGTYPE Small molecular drug DRUG0293 DISEASES Severe acute respiratory syndrome (SARS) DRUG0293 DRUGSTAT Preclinical Drug DRUG0293 TARGNAME SARS-CoV 3C-like protease (3CLpro) R1AB_CVHSA (3CLpro) DRUG0294 DRUGNAME PMID28624700-compound-3-31 DRUG0294 DRUGTYPE Small molecular drug DRUG0294 DISEASES Severe acute respiratory syndrome (SARS) DRUG0294 DRUGSTAT Preclinical Drug DRUG0294 TARGNAME SARS-CoV 3C-like protease (3CLpro) R1AB_CVHSA (3CLpro) DRUG0295 DRUGNAME PMID30784880-compound-6-5 DRUG0295 DRUGTYPE Small molecular drug DRUG0295 DISEASES Severe acute respiratory syndrome (SARS) DRUG0295 DRUGSTAT Preclinical Drug DRUG0295 TARGNAME SARS-CoV 3C-like protease (3CLpro) R1AB_CVHSA (3CLpro) DRUG0269 DRUGNAME Hexamethylene amiloride DRUG0269 DRUGTYPE Small molecular drug DRUG0269 DISEASES Severe acute respiratory syndrome (SARS) DRUG0269 DRUGSTAT Preclinical Drug DRUG0269 TARGNAME SARS-CoV envelope small membrane protein (E) VEMP_CVHSA DRUG0269 PCHEMCID CID: 1794 DRUG0165 DRUGNAME N-(2-aminoethyl)-1-aziridine-ethanamine DRUG0165 DRUGTYPE Small molecular drug DRUG0165 DISEASES Severe acute respiratory syndrome (SARS) DRUG0165 DRUGSTAT Investigative Agent DRUG0165 TARGNAME HUMAN angiotensin-converting enzyme 2 (ACE2) ACE2_HUMAN DRUG0125 DRUGNAME Imatinib DRUG0125 DRUGTYPE Small molecular drug DRUG0125 DISEASES Severe acute respiratory syndrome (SARS) DRUG0125 DRUGSTAT Investigative Agent DRUG0125 TARGNAME HUMAN fusion protein Bcr-Abl (Bcr-Abl) BCR_HUMAN-ABL1_HUMAN DRUG0125 PCHEMCID CID: 5291 DRUG0125 HIGHSTAT Approved DRUG0125 HIGHDISE Chronic myeloid leukaemia DRUG0267 DRUGNAME Dasatinib DRUG0267 DRUGTYPE Small molecular drug DRUG0267 DISEASES Severe acute respiratory syndrome (SARS) DRUG0267 DRUGSTAT Investigative Agent DRUG0267 TARGNAME HUMAN fusion protein Bcr-Abl (Bcr-Abl) BCR_HUMAN-ABL1_HUMAN DRUG0267 PCHEMCID CID: 3062316 DRUG0267 HIGHSTAT Approved DRUG0267 HIGHDISE Chronic myeloid leukaemia DRUG0266 DRUGNAME Trametinib DRUG0266 DRUGTYPE Small molecular drug DRUG0266 DISEASES Severe acute respiratory syndrome (SARS) DRUG0266 DRUGSTAT Investigative Agent DRUG0266 TARGNAME HUMAN ERK activator kinase 1 (MEK1) MP2K1_HUMAN DRUG0266 TARGNAME HUMAN ERK activator kinase 2 (MEK2) MP2K2_HUMAN DRUG0266 PCHEMCID CID: 11707110 DRUG0266 HIGHSTAT Approved DRUG0266 HIGHDISE Metastatic melanoma DRUG0265 DRUGNAME Selumetinib DRUG0265 DRUGTYPE Small molecular drug DRUG0265 DISEASES Severe acute respiratory syndrome (SARS) DRUG0265 DRUGSTAT Investigative Agent DRUG0265 TARGNAME HUMAN ERK activator kinase 1 (MEK1) MP2K1_HUMAN DRUG0265 TARGNAME HUMAN ERK activator kinase 2 (MEK2) MP2K2_HUMAN DRUG0265 PCHEMCID CID: 10127622 DRUG0265 HIGHSTAT Approved DRUG0265 HIGHDISE Neurofibromatosis type 1 DRUG0167 DRUGNAME Rapamycin DRUG0167 DRUGTYPE Small molecular drug DRUG0167 DISEASES Severe acute respiratory syndrome (SARS) DRUG0167 DRUGSTAT Investigative Agent DRUG0167 TARGNAME HUMAN mammalian target of rapamycin (mTOR) MTOR_HUMAN DRUG0167 PCHEMCID CID: 6436030 DRUG0167 HIGHSTAT Approved DRUG0167 HIGHDISE Lymphangioleiomyomatosis DRUG0168 DRUGNAME Everolimus DRUG0168 DRUGTYPE Small molecular drug DRUG0168 DISEASES Severe acute respiratory syndrome (SARS) DRUG0168 DRUGSTAT Investigative Agent DRUG0168 TARGNAME HUMAN mammalian target of rapamycin (mTOR) MTOR_HUMAN DRUG0168 PCHEMCID CID: 6442177 DRUG0168 HIGHSTAT Approved DRUG0168 HIGHDISE Advanced/metastatic breast cancer DRUG0152 DRUGNAME Ribavirin DRUG0152 DRUGTYPE Small molecular drug DRUG0152 DISEASES Severe acute respiratory syndrome (SARS) DRUG0152 DRUGSTAT Investigative Agent DRUG0152 TARGNAME SARS-CoV RNA-directed RNA polymerase (RdRp) R1AB_CVHSA (RdRp) DRUG0152 PCHEMCID CID: 37542 DRUG0152 HIGHSTAT Approved DRUG0152 HIGHDISE Hepatitis C virus infection DRUG0233 DRUGNAME Remdesivir DRUG0233 DRUGTYPE Small molecular drug DRUG0233 DISEASES Severe acute respiratory syndrome (SARS) DRUG0233 DRUGSTAT Investigative Agent DRUG0233 TARGNAME SARS-CoV RNA-directed RNA polymerase (RdRp) R1AB_CVHSA (RdRp) DRUG0233 PCHEMCID CID: 121304016 DRUG0291 DRUGNAME PMID20527968-compound-6577871 DRUG0291 DRUGTYPE Small molecular drug DRUG0291 DISEASES Severe acute respiratory syndrome (SARS) DRUG0291 DRUGSTAT Investigative Agent DRUG0291 TARGNAME SARS-CoV papain-like proteinase (PL-PRO) R1AB_CVHSA (PL-PRO) DRUG0292 DRUGNAME GRL-0667 DRUG0292 DRUGTYPE Small molecular drug DRUG0292 DISEASES Severe acute respiratory syndrome (SARS) DRUG0292 DRUGSTAT Investigative Agent DRUG0292 TARGNAME SARS-CoV papain-like proteinase (PL-PRO) R1AB_CVHSA (PL-PRO) DRUG0292 PCHEMCID CID: 46174170 DRUG0213 DRUGNAME Disulfiram DRUG0213 DRUGTYPE Small molecular drug DRUG0213 DISEASES Severe acute respiratory syndrome (SARS) DRUG0213 DRUGSTAT Investigative Agent DRUG0213 TARGNAME SARS-CoV papain-like proteinase (PL-PRO) R1AB_CVHSA (PL-PRO) DRUG0213 PCHEMCID CID: 3117 DRUG0213 HIGHSTAT Approved DRUG0213 HIGHDISE Alcohol dependence DRUG0171 DRUGNAME Camostat mesylate DRUG0171 DRUGTYPE Small molecular drug DRUG0171 DISEASES Severe acute respiratory syndrome (SARS) DRUG0171 DRUGSTAT Investigative Agent DRUG0171 TARGNAME HUMAN transmembrane protease serine 2 (TMPRSS2) TMPS2_HUMAN DRUG0171 PCHEMCID CID: 5284360 DRUG0305 DRUGNAME Griffithsin DRUG0305 DRUGTYPE Protein/peptide drug DRUG0305 DISEASES Severe acute respiratory syndrome (SARS) DRUG0305 DRUGSTAT Preclinical Drug DRUG0305 TARGNAME SARS-CoV spike glycoprotein (S) SPIKE_CVHSA DRUG0305 HIGHSTAT Phase 1 DRUG0305 HIGHDISE Human immunodeficiency virus infection DRUG0276 DRUGNAME PMID26911565-peptide-P9 DRUG0276 DRUGTYPE Protein/peptide drug DRUG0276 DISEASES Severe acute respiratory syndrome (SARS) DRUG0276 DRUGSTAT Preclinical Drug DRUG0276 TARGNAME SARS-CoV spike glycoprotein (S) SPIKE_CVHSA DRUG0264 DRUGNAME Alisporivir DRUG0264 DRUGTYPE Protein/peptide drug DRUG0264 DISEASES Severe acute respiratory syndrome (SARS) DRUG0264 DRUGSTAT Investigative Agent DRUG0264 TARGNAME HUMAN cyclophilin A (CYPA) PPIA_HUMAN DRUG0264 PCHEMCID CID: 11513676 DRUG0264 HIGHSTAT Phase 3 DRUG0264 HIGHDISE Hepatitis C virus infection DRUG0263 DRUGNAME Ciclosporin DRUG0263 DRUGTYPE Protein/peptide drug DRUG0263 DISEASES Severe acute respiratory syndrome (SARS) DRUG0263 DRUGSTAT Investigative Agent DRUG0263 TARGNAME HUMAN cyclophilin D (CYP3) PPIF_HUMAN DRUG0263 PCHEMCID CID: 24883466 DRUG0263 HIGHSTAT Approved DRUG0263 HIGHDISE Graft-versus-host disease DRUG0250 DRUGNAME Fusion peptide EK1 DRUG0250 DRUGTYPE Protein/peptide drug DRUG0250 DISEASES Severe acute respiratory syndrome (SARS) DRUG0250 DRUGSTAT Investigative Agent DRUG0250 TARGNAME SARS-CoV spike glycoprotein S2' HR1 region (S S2'HR1) SPIKE_CVHSA (S2'HR1) DRUG0197 DRUGNAME Triflupromazine DRUG0197 DRUGTYPE Small molecular drug DRUG0197 DISEASES Severe acute respiratory syndrome (SARS) DRUG0197 DRUGSTAT Investigative Agent DRUG0197 TARGNAME HUMAN clathrin-mediated endocytosis (RME) N.A. DRUG0197 PCHEMCID CID: 5568 DRUG0197 HIGHSTAT Withdrawn from market DRUG0197 HIGHDISE Schizophrenia DRUG0200 DRUGNAME Promethazine DRUG0200 DRUGTYPE Small molecular drug DRUG0200 DISEASES Severe acute respiratory syndrome (SARS) DRUG0200 DRUGSTAT Investigative Agent DRUG0200 TARGNAME HUMAN clathrin-mediated endocytosis (RME) N.A. DRUG0200 PCHEMCID CID: 4927 DRUG0198 DRUGNAME Fluphenazine DRUG0198 DRUGTYPE Small molecular drug DRUG0198 DISEASES Severe acute respiratory syndrome (SARS) DRUG0198 DRUGSTAT Investigative Agent DRUG0198 TARGNAME HUMAN clathrin-mediated endocytosis (RME) N.A. DRUG0198 PCHEMCID CID: 3372 DRUG0199 DRUGNAME Chlorpromazine DRUG0199 DRUGTYPE Small molecular drug DRUG0199 DISEASES Severe acute respiratory syndrome (SARS) DRUG0199 DRUGSTAT Investigative Agent DRUG0199 TARGNAME HUMAN clathrin-mediated endocytosis (RME) N.A. DRUG0199 PCHEMCID CID: 2726 DRUG0199 HIGHSTAT Withdrawn from market DRUG0199 HIGHDISE Schizophrenia DRUG0121 DRUGNAME Oseltamivir DRUG0121 DRUGTYPE Small molecular drug DRUG0121 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0121 DRUGSTAT Drug in Phase 3 Clinical Trial DRUG0121 PCHEMCID CID: 65028 DRUG0121 HIGHSTAT Approved DRUG0121 HIGHDISE Influenza virus infection DRUG0122 DRUGNAME Tradipitant DRUG0122 DRUGTYPE Small molecular drug DRUG0122 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0122 DRUGSTAT Drug in Phase 3 Clinical Trial DRUG0122 PCHEMCID CID: 9916461 DRUG0123 DRUGNAME Azithromycin DRUG0123 DRUGTYPE Small molecular drug DRUG0123 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0123 DRUGSTAT Drug in Phase 3 Clinical Trial DRUG0123 PCHEMCID CID: 447043 DRUG0123 HIGHSTAT Approved DRUG0123 HIGHDISE Bronchitis DRUG0124 DRUGNAME Methylprednisolone DRUG0124 DRUGTYPE Small molecular drug DRUG0124 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0124 DRUGSTAT Drug in Phase 3 Clinical Trial DRUG0124 PCHEMCID CID: 6741 DRUG0124 HIGHSTAT Approved DRUG0124 HIGHDISE Rheumatoid arthritis DRUG0125 DRUGNAME Imatinib DRUG0125 DRUGTYPE Small molecular drug DRUG0125 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0125 DRUGSTAT Drug in Phase 3 Clinical Trial DRUG0125 PCHEMCID CID: 5291 DRUG0125 HIGHSTAT Approved DRUG0125 HIGHDISE Chronic myeloid leukaemia DRUG0126 DRUGNAME Ciclesonide DRUG0126 DRUGTYPE Small molecular drug DRUG0126 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0126 DRUGSTAT Drug in Phase 3 Clinical Trial DRUG0126 PCHEMCID CID: 6918155 DRUG0126 HIGHSTAT Approved DRUG0126 HIGHDISE Asthma DRUG0127 DRUGNAME Nitazoxanide DRUG0127 DRUGTYPE Small molecular drug DRUG0127 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0127 DRUGSTAT Drug in Phase 3 Clinical Trial DRUG0127 PCHEMCID CID: 41684 DRUG0127 HIGHSTAT Approved DRUG0127 HIGHDISE Diarrhea DRUG0111 DRUGNAME Ivermectin DRUG0111 DRUGTYPE Small molecular drug DRUG0111 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0111 DRUGSTAT Drug in Phase 2/3 Clinical Trial DRUG0111 PCHEMCID CID: 6321424 DRUG0111 HIGHSTAT Approved DRUG0111 HIGHDISE Onchocerciasis DRUG0112 DRUGNAME Ifenprodil DRUG0112 DRUGTYPE Small molecular drug DRUG0112 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0112 DRUGSTAT Drug in Phase 2/3 Clinical Trial DRUG0112 PCHEMCID CID: 3689 DRUG0067 DRUGNAME Arbidol DRUG0067 DRUGTYPE Small molecular drug DRUG0067 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0067 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0067 PCHEMCID CID: 131410 DRUG0067 HIGHSTAT Phase 4 DRUG0067 HIGHDISE Influenza virus infection DRUG0068 DRUGNAME Thalidomide DRUG0068 DRUGTYPE Small molecular drug DRUG0068 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0068 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0068 PCHEMCID CID: 5426 DRUG0068 HIGHSTAT Approved DRUG0068 HIGHDISE Multiple myeloma DRUG0069 DRUGNAME N-acetylcysteine DRUG0069 DRUGTYPE Small molecular drug DRUG0069 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0069 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0069 PCHEMCID CID: 12035 DRUG0069 HIGHSTAT Approved DRUG0069 HIGHDISE Cystic fibrosis DRUG0070 DRUGNAME Fingolimod DRUG0070 DRUGTYPE Small molecular drug DRUG0070 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0070 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0070 PCHEMCID CID: 107970 DRUG0070 HIGHSTAT Approved DRUG0070 HIGHDISE Multiple sclerosis DRUG0071 DRUGNAME Carrimycin DRUG0071 DRUGTYPE Small molecular drug DRUG0071 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0071 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0072 DRUGNAME Nitric Oxide DRUG0072 DRUGTYPE Small molecular drug DRUG0072 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0072 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0072 PCHEMCID CID: 145068 DRUG0072 HIGHSTAT Approved DRUG0072 HIGHDISE Hypertension DRUG0073 DRUGNAME Colchicine DRUG0073 DRUGTYPE Small molecular drug DRUG0073 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0073 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0073 PCHEMCID CID: 6167 DRUG0073 HIGHSTAT Approved DRUG0073 HIGHDISE Gout DRUG0074 DRUGNAME Tofacitinib DRUG0074 DRUGTYPE Small molecular drug DRUG0074 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0074 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0074 PCHEMCID CID: 9926791 DRUG0074 HIGHSTAT Approved DRUG0074 HIGHDISE Rheumatoid arthritis DRUG0075 DRUGNAME Piclidenoson DRUG0075 DRUGTYPE Small molecular drug DRUG0075 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0075 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0075 PCHEMCID CID: 123683 DRUG0075 HIGHSTAT Phase 3 DRUG0075 HIGHDISE Keratoconjunctivitis Sicca DRUG0076 DRUGNAME Defibrotide DRUG0076 DRUGTYPE Small molecular drug DRUG0076 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0076 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0076 PCHEMCID CID: 135565962 DRUG0076 HIGHSTAT Approved DRUG0076 HIGHDISE Hepatic Veno-Occlusive Disease DRUG0077 DRUGNAME Nintedanib DRUG0077 DRUGTYPE Small molecular drug DRUG0077 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0077 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0077 PCHEMCID CID: 135423438 DRUG0077 HIGHSTAT Approved DRUG0077 HIGHDISE Idiopathic pulmonary fibrosis DRUG0078 DRUGNAME Fluvoxamine DRUG0078 DRUGTYPE Small molecular drug DRUG0078 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0078 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0078 PCHEMCID CID: 5324346 DRUG0078 HIGHSTAT Approved DRUG0078 HIGHDISE Obsessive-compulsive disorder DRUG0079 DRUGNAME CM4620 DRUG0079 DRUGTYPE Small molecular drug DRUG0079 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0079 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0079 PCHEMCID CID: 122507647 DRUG0013 DRUGNAME Mefloquine DRUG0013 DRUGTYPE Small molecular drug DRUG0013 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0013 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0013 PCHEMCID CID: 40692 DRUG0013 HIGHSTAT Approved DRUG0013 HIGHDISE Malaria DRUG0080 DRUGNAME Clevudine DRUG0080 DRUGTYPE Small molecular drug DRUG0080 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0080 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0080 PCHEMCID CID: 73115 DRUG0080 HIGHSTAT Phase 4 DRUG0080 HIGHDISE Hepatitis B DRUG0081 DRUGNAME Triiodothyronine DRUG0081 DRUGTYPE Small molecular drug DRUG0081 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0081 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0081 PCHEMCID CID: 5920 DRUG0081 HIGHSTAT Approved DRUG0081 HIGHDISE Euthyroid goiter DRUG0082 DRUGNAME Selinexor DRUG0082 DRUGTYPE Small molecular drug DRUG0082 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0082 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0082 PCHEMCID CID: 71481097 DRUG0082 HIGHSTAT Approved DRUG0082 HIGHDISE Multiple myeloma DRUG0083 DRUGNAME Etoposide DRUG0083 DRUGTYPE Small molecular drug DRUG0083 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0083 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0083 PCHEMCID CID: 36462 DRUG0083 HIGHSTAT Approved DRUG0083 HIGHDISE Testicular neoplasms DRUG0084 DRUGNAME AT-001 DRUG0084 DRUGTYPE Small molecular drug DRUG0084 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0084 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0084 PCHEMCID CID: 56639723 DRUG0085 DRUGNAME Ketamine DRUG0085 DRUGTYPE Small molecular drug DRUG0085 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0085 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0085 PCHEMCID CID: 3821 DRUG0085 HIGHSTAT Approved DRUG0085 HIGHDISE Anaesthesia DRUG0086 DRUGNAME Naltrexone DRUG0086 DRUGTYPE Small molecular drug DRUG0086 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0086 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0086 PCHEMCID CID: 5360515 DRUG0086 HIGHSTAT Approved DRUG0086 HIGHDISE Alcoholism DRUG0087 DRUGNAME Melphalan DRUG0087 DRUGTYPE Small molecular drug DRUG0087 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0087 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0087 PCHEMCID CID: 460612 DRUG0087 HIGHSTAT Approved DRUG0087 HIGHDISE Ovarian neoplasms DRUG0088 DRUGNAME ArtemiC DRUG0088 DRUGTYPE Small molecular drug DRUG0088 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0088 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0088 PCHEMCID CID: 11629819 DRUG0306 DRUGNAME VERU-111 DRUG0306 DRUGTYPE Small molecular drug DRUG0306 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0306 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0306 PCHEMCID CID: 53379371 DRUG0057 DRUGNAME Deferoxamine DRUG0057 DRUGTYPE Small molecular drug DRUG0057 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0057 DRUGSTAT Drug in Phase 1/2 Clinical Trial DRUG0057 PCHEMCID CID: 2973 DRUG0057 HIGHSTAT Approved DRUG0057 HIGHDISE Acute iron or aluminum toxicity DRUG0058 DRUGNAME Indomethacin DRUG0058 DRUGTYPE Small molecular drug DRUG0058 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0058 DRUGSTAT Drug in Phase 1/2 Clinical Trial DRUG0058 PCHEMCID CID: 3715 DRUG0058 HIGHSTAT Approved DRUG0058 HIGHDISE Rheumatoid arthritis DRUG0059 DRUGNAME Methotrexate DRUG0059 DRUGTYPE Small molecular drug DRUG0059 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0059 DRUGSTAT Drug in Phase 1/2 Clinical Trial DRUG0059 PCHEMCID CID: 126941 DRUG0059 HIGHSTAT Approved DRUG0059 HIGHDISE Choriocarcinoma DRUG0060 DRUGNAME AVM0703 DRUG0060 DRUGTYPE Small molecular drug DRUG0060 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0060 DRUGSTAT Drug in Phase 1/2 Clinical Trial DRUG0044 DRUGNAME TAK-981 DRUG0044 DRUGTYPE Small molecular drug DRUG0044 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0044 DRUGSTAT Drug in Phase 1 Clinical Trial DRUG0044 PCHEMCID CID: 118628567 DRUG0045 DRUGNAME Progesterone DRUG0045 DRUGTYPE Small molecular drug DRUG0045 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0045 DRUGSTAT Drug in Phase 1 Clinical Trial DRUG0045 PCHEMCID CID: 5994 DRUG0045 HIGHSTAT Approved DRUG0045 HIGHDISE Amenorrhea DRUG0046 DRUGNAME Sulfonatoporphyrin DRUG0046 DRUGTYPE Small molecular drug DRUG0046 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0046 DRUGSTAT Drug in Phase 1 Clinical Trial DRUG0046 PCHEMCID CID: 129653953 DRUG0047 DRUGNAME SnPP Protoporphyrin DRUG0047 DRUGTYPE Small molecular drug DRUG0047 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0047 DRUGSTAT Drug in Phase 1 Clinical Trial DRUG0047 PCHEMCID CID: 73755113 DRUG0048 DRUGNAME Plitidepsin DRUG0048 DRUGTYPE Small molecular drug DRUG0048 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0048 DRUGSTAT Drug in Phase 1 Clinical Trial DRUG0048 PCHEMCID CID: 9812534 DRUG0139 DRUGNAME TMCB DRUG0139 DRUGTYPE Small molecular drug DRUG0139 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0139 DRUGSTAT Investigative Agent DRUG0139 PCHEMCID CID: 46943415 DRUG0140 DRUGNAME Indinavir DRUG0140 DRUGTYPE Small molecular drug DRUG0140 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0140 DRUGSTAT Investigative Agent DRUG0140 PCHEMCID CID: 5362440 DRUG0140 HIGHSTAT Approved DRUG0140 HIGHDISE HIV infections DRUG0141 DRUGNAME Amprenavir DRUG0141 DRUGTYPE Small molecular drug DRUG0141 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0141 DRUGSTAT Investigative Agent DRUG0141 PCHEMCID CID: 65016 DRUG0141 HIGHSTAT Approved DRUG0141 HIGHDISE HIV infections DRUG0142 DRUGNAME Triazavirin DRUG0142 DRUGTYPE Small molecular drug DRUG0142 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0142 DRUGSTAT Investigative Agent DRUG0142 PCHEMCID CID: 3113817 DRUG0142 HIGHSTAT Phase 2 DRUG0142 HIGHDISE Influenza virus infection DRUG0143 DRUGNAME Linezolid DRUG0143 DRUGTYPE Small molecular drug DRUG0143 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0143 DRUGSTAT Investigative Agent DRUG0143 PCHEMCID CID: 441401 DRUG0143 HIGHSTAT Approved DRUG0143 HIGHDISE Bacterial infections DRUG0144 DRUGNAME Oxymethalone DRUG0144 DRUGTYPE Small molecular drug DRUG0144 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0144 DRUGSTAT Investigative Agent DRUG0144 PCHEMCID CID: 5281034 DRUG0145 DRUGNAME Heparin DRUG0145 DRUGTYPE Small molecular drug DRUG0145 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0145 DRUGSTAT Investigative Agent DRUG0145 PCHEMCID CID: 772 DRUG0145 HIGHSTAT Approved DRUG0145 HIGHDISE Venous thrombosis DRUG0146 DRUGNAME EIDD-2801 DRUG0146 DRUGTYPE Small molecular drug DRUG0146 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0146 DRUGSTAT Investigative Agent DRUG0146 PCHEMCID CID: 145996610 DRUG0147 DRUGNAME EIDD-1931 DRUG0147 DRUGTYPE Small molecular drug DRUG0147 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0147 DRUGSTAT Investigative Agent DRUG0147 PCHEMCID CID: 353014 DRUG0128 DRUGNAME DAS181 DRUG0128 DRUGTYPE Protein/peptide drug DRUG0128 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0128 DRUGSTAT Drug in Phase 3 Clinical Trial DRUG0128 PCHEMCID SID: 381125922 DRUG0129 DRUGNAME Interferon beta-1a DRUG0129 DRUGTYPE Protein/peptide drug DRUG0129 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0129 DRUGSTAT Drug in Phase 3 Clinical Trial DRUG0129 HIGHSTAT Approved DRUG0129 HIGHDISE Multiple sclerosis DRUG0113 DRUGNAME Aviptadil DRUG0113 DRUGTYPE Protein/peptide drug DRUG0113 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0113 DRUGSTAT Drug in Phase 2/3 Clinical Trial DRUG0113 PCHEMCID CID: 16132300 DRUG0114 DRUGNAME Angiotensin (1-7) DRUG0114 DRUGTYPE Protein/peptide drug DRUG0114 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0114 DRUGSTAT Drug in Phase 2/3 Clinical Trial DRUG0114 PCHEMCID CID: 123805 DRUG0089 DRUGNAME Thymosin DRUG0089 DRUGTYPE Protein/peptide drug DRUG0089 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0089 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0089 PCHEMCID CID: 44286042 DRUG0090 DRUGNAME Pegylated interferon lambda DRUG0090 DRUGTYPE Protein/peptide drug DRUG0090 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0090 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0091 DRUGNAME Peginterferon lambda alfa-1a DRUG0091 DRUGTYPE Protein/peptide drug DRUG0091 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0091 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0092 DRUGNAME Peginterferon lambda-1a DRUG0092 DRUGTYPE Protein/peptide drug DRUG0092 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0092 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0093 DRUGNAME Dornase alfa DRUG0093 DRUGTYPE Protein/peptide drug DRUG0093 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0093 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0093 HIGHSTAT Approved DRUG0093 HIGHDISE Cystic fibrosis DRUG0094 DRUGNAME DFV890 DRUG0094 DRUGTYPE Protein/peptide drug DRUG0094 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0094 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0037 DRUGNAME Interferon-alpha 2b DRUG0037 DRUGTYPE Protein/peptide drug DRUG0037 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0037 DRUGSTAT Drug in Early Phase 1 Clinical Trial DRUG0037 HIGHSTAT Approved DRUG0037 HIGHDISE Hairy cell leukemia DRUG0148 DRUGNAME BXT-25 DRUG0148 DRUGTYPE Protein/peptide drug DRUG0148 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0148 DRUGSTAT Investigative Agent DRUG0130 DRUGNAME Ritonavir + oseltamivir DRUG0130 DRUGTYPE Combination drug DRUG0130 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0130 DRUGSTAT Drug in Phase 3 Clinical Trial DRUG0131 DRUGNAME Hydroxychloroquine + camostat mesylate DRUG0131 DRUGTYPE Combination drug DRUG0131 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0131 DRUGSTAT Drug in Phase 3 Clinical Trial DRUG0132 DRUGNAME Hydroxychloroquine + intravenous famotidine DRUG0132 DRUGTYPE Combination drug DRUG0132 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0132 DRUGSTAT Drug in Phase 3 Clinical Trial DRUG0133 DRUGNAME Hydroxychloroquine + azithromycin DRUG0133 DRUGTYPE Combination drug DRUG0133 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0133 DRUGSTAT Drug in Phase 3 Clinical Trial DRUG0134 DRUGNAME Diltiazem + niclosamide DRUG0134 DRUGTYPE Combination drug DRUG0134 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0134 DRUGSTAT Drug in Phase 3 Clinical Trial DRUG0135 DRUGNAME Nitazoxanide + ivermectin + chloroquine DRUG0135 DRUGTYPE Combination drug DRUG0135 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0135 DRUGSTAT Drug in Phase 3 Clinical Trial DRUG0136 DRUGNAME Levamisole + isoprinosine DRUG0136 DRUGTYPE Combination drug DRUG0136 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0136 DRUGSTAT Drug in Phase 3 Clinical Trial DRUG0115 DRUGNAME Levamisole Pill + Budesonide+Formoterol inhaler DRUG0115 DRUGTYPE Combination drug DRUG0115 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0115 DRUGSTAT Drug in Phase 2/3 Clinical Trial DRUG0116 DRUGNAME Lopinavir + ritonavir + hydoxychloroquine DRUG0116 DRUGTYPE Combination drug DRUG0116 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0116 DRUGSTAT Drug in Phase 2/3 Clinical Trial DRUG0117 DRUGNAME Ivermectin + nitazoxanide DRUG0117 DRUGTYPE Combination drug DRUG0117 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0117 DRUGSTAT Drug in Phase 2/3 Clinical Trial DRUG0118 DRUGNAME Hydroxychloroquine + nitazoxanide DRUG0118 DRUGTYPE Combination drug DRUG0118 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0118 DRUGSTAT Drug in Phase 2/3 Clinical Trial DRUG0119 DRUGNAME Metenkefalin + tridecactide DRUG0119 DRUGTYPE Combination drug DRUG0119 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0119 DRUGSTAT Drug in Phase 2/3 Clinical Trial DRUG0120 DRUGNAME RPH-104 + Olokizumab DRUG0120 DRUGTYPE Combination drug DRUG0120 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0120 DRUGSTAT Drug in Phase 2/3 Clinical Trial DRUG0095 DRUGNAME Thalidomide + hormones DRUG0095 DRUGTYPE Combination drug DRUG0095 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0095 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0096 DRUGNAME Ribavirin + lopinavir + ritonavir + interferon beta-1b DRUG0096 DRUGTYPE Combination drug DRUG0096 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0096 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0097 DRUGNAME N-acetylcysteine + Fuzheng Huayu DRUG0097 DRUGTYPE Combination drug DRUG0097 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0097 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0098 DRUGNAME Danoprevir + ritonavir + interferon DRUG0098 DRUGTYPE Combination drug DRUG0098 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0098 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0099 DRUGNAME Danoprevir + ritonavir DRUG0099 DRUGTYPE Combination drug DRUG0099 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0099 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0100 DRUGNAME Atovaquone + azithromycin DRUG0100 DRUGTYPE Combination drug DRUG0100 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0100 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0101 DRUGNAME Hydroxychloroquine + azithromycin + tocilizumab DRUG0101 DRUGTYPE Combination drug DRUG0101 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0101 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0102 DRUGNAME Mefloquine + azithromycin DRUG0102 DRUGTYPE Combination drug DRUG0102 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0102 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0103 DRUGNAME Mefloquine + azithromycin + tocilizumab DRUG0103 DRUGTYPE Combination drug DRUG0103 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0103 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0104 DRUGNAME Ruxolitinib + simvastatin DRUG0104 DRUGTYPE Combination drug DRUG0104 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0104 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0105 DRUGNAME Hydroxychloroquine + ivermectin DRUG0105 DRUGTYPE Combination drug DRUG0105 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0105 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0049 DRUGNAME Hydroxychloroquin + azithromycin + ivermectin DRUG0049 DRUGTYPE Combination drug DRUG0049 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0049 DRUGSTAT Drug in Phase 1 Clinical Trial DRUG0050 DRUGNAME MCN (Methylene blue, vitamin C, N-acetyl cysteine) DRUG0050 DRUGTYPE Combination drug DRUG0050 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0050 DRUGSTAT Drug in Phase 1 Clinical Trial DRUG0106 DRUGNAME Umbilical Cord Mesenchymal Stem Cells DRUG0106 DRUGTYPE Cell therapy DRUG0106 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0106 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0107 DRUGNAME Mesenchymal stem cells DRUG0107 DRUGTYPE Cell therapy DRUG0107 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0107 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0107 HIGHSTAT Approved DRUG0107 HIGHDISE Epidermolysis Bullosa DRUG0108 DRUGNAME HB-adMSCs cell DRUG0108 DRUGTYPE Cell therapy DRUG0108 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0108 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0109 DRUGNAME Mesenchymal stromal cells DRUG0109 DRUGTYPE Cell therapy DRUG0109 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0109 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0110 DRUGNAME Dialyzable leukocyte cell DRUG0110 DRUGTYPE Cell therapy DRUG0110 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0110 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0066 DRUGNAME Ad5-nCoV DRUG0066 DRUGTYPE Vaccine DRUG0066 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0066 DRUGSTAT Drug in Phase 2 Clinical Trial DRUG0061 DRUGNAME Natural killer cells DRUG0061 DRUGTYPE Cell therapy DRUG0061 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0061 DRUGSTAT Drug in Phase 1/2 Clinical Trial DRUG0062 DRUGNAME Allogeneic human dental pulp stem cells (BSH BTC & Utooth BTC) DRUG0062 DRUGTYPE Cell therapy DRUG0062 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0062 DRUGSTAT Drug in Phase 1/2 Clinical Trial DRUG0063 DRUGNAME Allogeneic NK transfer DRUG0063 DRUGTYPE Cell therapy DRUG0063 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0063 DRUGSTAT Drug in Phase 1/2 Clinical Trial DRUG0064 DRUGNAME BM-MSCs cell DRUG0064 DRUGTYPE Cell therapy DRUG0064 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0064 DRUGSTAT Drug in Phase 1/2 Clinical Trial DRUG0065 DRUGNAME CYNK-001 DRUG0065 DRUGTYPE Cell therapy DRUG0065 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0065 DRUGSTAT Drug in Phase 1/2 Clinical Trial DRUG0054 DRUGNAME LV-SMENP-DC DRUG0054 DRUGTYPE Vaccine DRUG0054 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0054 DRUGSTAT Drug in Phase 1/2 Clinical Trial DRUG0055 DRUGNAME ChAdOx1 nCoV-19 DRUG0055 DRUGTYPE Vaccine DRUG0055 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0055 DRUGSTAT Drug in Phase 1/2 Clinical Trial DRUG0056 DRUGNAME BNT162a1 DRUG0056 DRUGTYPE Vaccine DRUG0056 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0056 DRUGSTAT Drug in Phase 1/2 Clinical Trial DRUG0051 DRUGNAME Wharton's Jelly-Mesenchymal Stem Cells DRUG0051 DRUGTYPE Cell therapy DRUG0051 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0051 DRUGSTAT Drug in Phase 1 Clinical Trial DRUG0052 DRUGNAME Nest mesenchymal stem cells DRUG0052 DRUGTYPE Cell therapy DRUG0052 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0052 DRUGSTAT Drug in Phase 1 Clinical Trial DRUG0053 DRUGNAME FT516 DRUG0053 DRUGTYPE Cell therapy DRUG0053 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0053 DRUGSTAT Drug in Phase 1 Clinical Trial DRUG0038 DRUGNAME mRNA-1273 DRUG0038 DRUGTYPE Vaccine DRUG0038 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0038 DRUGSTAT Drug in Phase 1 Clinical Trial DRUG0039 DRUGNAME Pathogen-specific aAPC DRUG0039 DRUGTYPE Vaccine DRUG0039 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0039 DRUGSTAT Drug in Phase 1 Clinical Trial DRUG0040 DRUGNAME Covid-19 aAPC DRUG0040 DRUGTYPE Vaccine DRUG0040 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0040 DRUGSTAT Drug in Phase 1 Clinical Trial DRUG0041 DRUGNAME BacTRL-Spike DRUG0041 DRUGTYPE Vaccine DRUG0041 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0041 DRUGSTAT Drug in Phase 1 Clinical Trial DRUG0042 DRUGNAME INO-4800 DRUG0042 DRUGTYPE Vaccine DRUG0042 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0042 DRUGSTAT Drug in Phase 1 Clinical Trial DRUG0043 DRUGNAME SARS-CoV-2 rS vaccine DRUG0043 DRUGTYPE Vaccine DRUG0043 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0043 DRUGSTAT Drug in Phase 1 Clinical Trial DRUG0149 DRUGNAME TNX-1800 vaccine DRUG0149 DRUGTYPE Vaccine DRUG0149 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0149 DRUGSTAT Preclinical Drug DRUG0150 DRUGNAME Li-Key peptide vaccine DRUG0150 DRUGTYPE Vaccine DRUG0150 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0150 DRUGSTAT Preclinical Drug DRUG0137 DRUGNAME Linear DNA vaccine DRUG0137 DRUGTYPE Vaccine DRUG0137 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0137 DRUGSTAT Investigative Agent DRUG0138 DRUGNAME NasoVAX vaccine DRUG0138 DRUGTYPE Vaccine DRUG0138 DISEASES Coronavirus Disease 2019 (COVID-19) DRUG0138 DRUGSTAT Investigative Agent DRUG0011 DRUGNAME Loperamide DRUG0011 DRUGTYPE Small molecular drug DRUG0011 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0011 DRUGSTAT Preclinical Drug DRUG0011 PCHEMCID CID: 3955 DRUG0011 HIGHSTAT Approved DRUG0011 HIGHDISE Diarrhea DRUG0012 DRUGNAME Amodiaquine DRUG0012 DRUGTYPE Small molecular drug DRUG0012 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0012 DRUGSTAT Preclinical Drug DRUG0012 PCHEMCID CID: 2165 DRUG0012 HIGHSTAT Withdrawn from market DRUG0012 HIGHDISE Malaria DRUG0013 DRUGNAME Mefloquine DRUG0013 DRUGTYPE Small molecular drug DRUG0013 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0013 DRUGSTAT Preclinical Drug DRUG0013 PCHEMCID CID: 40692 DRUG0013 HIGHSTAT Approved DRUG0013 HIGHDISE Malaria DRUG0014 DRUGNAME Gemcitabine DRUG0014 DRUGTYPE Small molecular drug DRUG0014 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0014 DRUGSTAT Preclinical Drug DRUG0014 PCHEMCID CID: 60750 DRUG0014 HIGHSTAT Approved DRUG0014 HIGHDISE Non-small cell lung cancer DRUG0015 DRUGNAME K22 DRUG0015 DRUGTYPE Small molecular drug DRUG0015 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0015 DRUGSTAT Preclinical Drug DRUG0036 DRUGNAME Resveratrol DRUG0036 DRUGTYPE Small molecular drug DRUG0036 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0036 DRUGSTAT Preclinical Drug DRUG0036 PCHEMCID CID: 445154 DRUG0010 DRUGNAME Chloroquine DRUG0010 DRUGTYPE Small molecular drug DRUG0010 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0010 DRUGSTAT Investigative Agent DRUG0010 PCHEMCID CID: 2719 DRUG0010 HIGHSTAT Withdrawn from market DRUG0010 HIGHDISE Malaria DRUG0030 DRUGNAME Saracatinib DRUG0030 DRUGTYPE Small molecular drug DRUG0030 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0030 DRUGSTAT Investigative Agent DRUG0030 PCHEMCID CID: 10302451 DRUG0030 HIGHSTAT Phase 2 DRUG0030 HIGHDISE Metastatic colorectal cancer DRUG0031 DRUGNAME Emetine hydrochloride DRUG0031 DRUGTYPE Small molecular drug DRUG0031 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0031 DRUGSTAT Investigative Agent DRUG0031 PCHEMCID CID: 10219 DRUG0032 DRUGNAME Monensin sodium DRUG0032 DRUGTYPE Small molecular drug DRUG0032 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0032 DRUGSTAT Investigative Agent DRUG0032 PCHEMCID CID: 23667299 DRUG0033 DRUGNAME Phenazopyridine DRUG0033 DRUGTYPE Small molecular drug DRUG0033 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0033 DRUGSTAT Investigative Agent DRUG0033 PCHEMCID CID: 4756 DRUG0034 DRUGNAME Mycophenolate mofetil DRUG0034 DRUGTYPE Small molecular drug DRUG0034 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0034 DRUGSTAT Investigative Agent DRUG0034 PCHEMCID CID: 5281078 DRUG0035 DRUGNAME Pyrvinium pamoate DRUG0035 DRUGTYPE Small molecular drug DRUG0035 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0035 DRUGSTAT Investigative Agent DRUG0035 PCHEMCID CID: 54680693 DRUG0017 DRUGNAME SAB-301 DRUG0017 DRUGTYPE Polyclonal antibody DRUG0017 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0017 DRUGSTAT Discontinue Drug in Phase 1 Clinical Trial DRUG0018 DRUGNAME REGN3048 + REGN3051 mabs DRUG0018 DRUGTYPE Combination drug DRUG0018 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0018 DRUGSTAT Discontinue Drug in Phase 1 Clinical Trial DRUG0024 DRUGNAME MVA-MERS-S_DF-1 vaccine DRUG0024 DRUGTYPE Vaccine DRUG0024 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0024 DRUGSTAT Drug in Phase 1b Clinical Trial DRUG0021 DRUGNAME GLS-5300 DRUG0021 DRUGTYPE Vaccine DRUG0021 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0021 DRUGSTAT Drug in Phase 1/2 Clinical Trial DRUG0022 DRUGNAME BVRS-GamVac-Combi DRUG0022 DRUGTYPE Vaccine DRUG0022 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0022 DRUGSTAT Drug in Phase 1/2 Clinical Trial DRUG0023 DRUGNAME BVRS-GamVac DRUG0023 DRUGTYPE Vaccine DRUG0023 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0023 DRUGSTAT Drug in Phase 1/2 Clinical Trial DRUG0019 DRUGNAME ChAdOx1 MERS001 DRUG0019 DRUGTYPE Vaccine DRUG0019 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0019 DRUGSTAT Drug in Phase 1 Clinical Trial DRUG0020 DRUGNAME ChAdOx1 MERS002 DRUG0020 DRUGTYPE Vaccine DRUG0020 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0020 DRUGSTAT Drug in Phase 1 Clinical Trial DRUG0025 DRUGNAME MERS-CoV SDNA DRUG0025 DRUGTYPE Vaccine DRUG0025 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0025 DRUGSTAT Investigative Agent DRUG0026 DRUGNAME rMERS-CoV E DRUG0026 DRUGTYPE Vaccine DRUG0026 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0026 DRUGSTAT Investigative Agent DRUG0027 DRUGNAME VRP S DRUG0027 DRUGTYPE Vaccine DRUG0027 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0027 DRUGSTAT Investigative Agent DRUG0028 DRUGNAME S(377-588)-Fc DRUG0028 DRUGTYPE Vaccine DRUG0028 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0028 DRUGSTAT Investigative Agent DRUG0029 DRUGNAME MERS-CoVS-containing nanoparticles DRUG0029 DRUGTYPE Vaccine DRUG0029 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0029 DRUGSTAT Investigative Agent DRUG0016 DRUGNAME MVA-MERS-S vaccine DRUG0016 DRUGTYPE Vaccine DRUG0016 DISEASES Middle East Respiratory Syndrome (MERS) DRUG0016 DRUGSTAT Discontinue Drug in Phase 1 Clinical Trial DRUG0011 DRUGNAME Loperamide DRUG0011 DRUGTYPE Small molecular drug DRUG0011 DISEASES Severe acute respiratory syndrome (SARS) DRUG0011 DRUGSTAT Preclinical Drug DRUG0011 PCHEMCID CID: 3955 DRUG0011 HIGHSTAT Approved DRUG0011 HIGHDISE Diarrhea DRUG0012 DRUGNAME Amodiaquine DRUG0012 DRUGTYPE Small molecular drug DRUG0012 DISEASES Severe acute respiratory syndrome (SARS) DRUG0012 DRUGSTAT Preclinical Drug DRUG0012 PCHEMCID CID: 2165 DRUG0012 HIGHSTAT Withdrawn from market DRUG0012 HIGHDISE Malaria DRUG0013 DRUGNAME Mefloquine DRUG0013 DRUGTYPE Small molecular drug DRUG0013 DISEASES Severe acute respiratory syndrome (SARS) DRUG0013 DRUGSTAT Preclinical Drug DRUG0013 PCHEMCID CID: 40692 DRUG0013 HIGHSTAT Approved DRUG0013 HIGHDISE Malaria DRUG0014 DRUGNAME Gemcitabine DRUG0014 DRUGTYPE Small molecular drug DRUG0014 DISEASES Severe acute respiratory syndrome (SARS) DRUG0014 DRUGSTAT Preclinical Drug DRUG0014 PCHEMCID CID: 60750 DRUG0014 HIGHSTAT Approved DRUG0014 HIGHDISE Non-small cell lung cancer DRUG0015 DRUGNAME K22 DRUG0015 DRUGTYPE Small molecular drug DRUG0015 DISEASES Severe acute respiratory syndrome (SARS) DRUG0015 DRUGSTAT Preclinical Drug DRUG0006 DRUGNAME Zanamivir DRUG0006 DRUGTYPE Small molecular drug DRUG0006 DISEASES Severe acute respiratory syndrome (SARS) DRUG0006 DRUGSTAT Investigative Agent DRUG0006 PCHEMCID CID: 60855 DRUG0006 HIGHSTAT Approved DRUG0006 HIGHDISE Influenza DRUG0007 DRUGNAME Rimantadine DRUG0007 DRUGTYPE Small molecular drug DRUG0007 DISEASES Severe acute respiratory syndrome (SARS) DRUG0007 DRUGSTAT Investigative Agent DRUG0007 PCHEMCID CID: 5071 DRUG0007 HIGHSTAT Approved DRUG0007 HIGHDISE Influenza DRUG0008 DRUGNAME 4E2Rcat DRUG0008 DRUGTYPE Small molecular drug DRUG0008 DISEASES Severe acute respiratory syndrome (SARS) DRUG0008 DRUGSTAT Investigative Agent DRUG0008 PCHEMCID CID: 2287236 DRUG0009 DRUGNAME Amantadine DRUG0009 DRUGTYPE Small molecular drug DRUG0009 DISEASES Severe acute respiratory syndrome (SARS) DRUG0009 DRUGSTAT Investigative Agent DRUG0009 PCHEMCID CID: 2130 DRUG0009 HIGHSTAT Approved DRUG0009 HIGHDISE Influenza DRUG0010 DRUGNAME Chloroquine DRUG0010 DRUGTYPE Small molecular drug DRUG0010 DISEASES Severe acute respiratory syndrome (SARS) DRUG0010 DRUGSTAT Investigative Agent DRUG0010 PCHEMCID CID: 2719 DRUG0010 HIGHSTAT Withdrawn from market DRUG0010 HIGHDISE Malaria DRUG0005 DRUGNAME Streptokinase DRUG0005 DRUGTYPE Protein/peptide drug DRUG0005 DISEASES Severe acute respiratory syndrome (SARS) DRUG0005 DRUGSTAT Discontinue Drug in Phase 3 Clinical Trial DRUG0005 HIGHSTAT Phase 4 DRUG0005 HIGHDISE Acute Myocardial Infarction DRUG0004 DRUGNAME Alferon LDO DRUG0004 DRUGTYPE Protein/peptide drug DRUG0004 DISEASES Severe acute respiratory syndrome (SARS) DRUG0004 DRUGSTAT Discontinue Drug in Phase 2 Clinical Trial DRUG0001 DRUGNAME VRC-SRSDNA015-00-VP vaccine DRUG0001 DRUGTYPE Vaccine DRUG0001 DISEASES Severe acute respiratory syndrome (SARS) DRUG0001 DRUGSTAT Discontinue Drug in Phase 1 Clinical Trial DRUG0002 DRUGNAME SARS-CoV vaccine DRUG0002 DRUGTYPE Vaccine DRUG0002 DISEASES Severe acute respiratory syndrome (SARS) DRUG0002 DRUGSTAT Discontinue Drug in Phase 1 Clinical Trial DRUG0003 DRUGNAME Recombinant S protein SARS vaccine DRUG0003 DRUGTYPE Vaccine DRUG0003 DISEASES Severe acute respiratory syndrome (SARS) DRUG0003 DRUGSTAT Discontinue Drug in Phase 1 Clinical Trial